<SEC-DOCUMENT>0001140361-25-006655.txt : 20250303
<SEC-HEADER>0001140361-25-006655.hdr.sgml : 20250303
<ACCEPTANCE-DATETIME>20250303074619
ACCESSION NUMBER:		0001140361-25-006655
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		15
FILED AS OF DATE:		20250303
DATE AS OF CHANGE:		20250303

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OCCIDENTAL PETROLEUM CORP /DE/
		CENTRAL INDEX KEY:			0000797468
		STANDARD INDUSTRIAL CLASSIFICATION:	CRUDE PETROLEUM & NATURAL GAS [1311]
		ORGANIZATION NAME:           	01 Energy & Transportation
		IRS NUMBER:				954035997
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-266420
		FILM NUMBER:		25693808

	BUSINESS ADDRESS:	
		STREET 1:		5 GREENWAY PLAZA
		STREET 2:		SUITE 110
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77046
		BUSINESS PHONE:		7132157000

	MAIL ADDRESS:	
		STREET 1:		5 GREENWAY PLAZA
		STREET 2:		SUITE 110
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77046
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>ny20044010x1_424b2.htm
<DESCRIPTION>424B2
<TEXT>
<html><head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.1.1.5279
         Copyright 1995 - 2025 Broadridge -->
  </head><body style="color: #000000;" bgcolor="#ffffff">
<!--Begin Page 1-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 456pt;"><a name="ny20044010x1_424b2_100-cov_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 456pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: right;">Filed Pursuant to Rule&#160;424(b)(2) <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: right;">Registration No. 333-266420<font style="font-weight: normal;"> </font></div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 43.5pt; margin-left: 0pt; text-align: left;">Prospectus Supplement <br></div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">(To Prospectus dated July&#160;29, 2022)<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 16pt; font-weight: bold; margin-top: 19.5pt; text-align: center;">74,020,695 Shares </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 13.25pt; text-align: center;"><img style="height: 111px; width: 107px;" src="logo_oxy3.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;">Common Stock </div><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 14.25pt;"> </div></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">This prospectus supplement relates to the issuance and sale of up to 74,020,695 shares of its common stock, par value $0.20 per share (the &#8220;Common Stock&#8221;), by Occidental Petroleum Corporation (&#8220;Occidental&#8221;) upon the exercise of warrants issued by Occidental on August&#160;3, 2020 (each, a &#8220;Warrant&#8221; and, collectively, the &#8220;Warrants&#8221;). </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Our Common Stock is listed on the New York Stock Exchange (&#8220;NYSE&#8221;) under the symbol &#8220;OXY.&#8221; On February&#160;28, 2025, the last reported sale price of our Common Stock on the NYSE was $48.84 per share. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The Warrants may be exercised at any time in accordance with their terms until August&#160;3, 2027, which is seven years after the date of the original issuance. Each Warrant entitles the holder to purchase from us one share of our Common Stock at an initial exercise price of $22.00 per share. The Warrants have been issued by Occidental pursuant to a warrant agreement, dated July&#160;24, 2020, between Occidental and Equiniti Trust Company, as Warrant Agent (the &#8220;Warrant Agreement&#8221;). The Warrants are listed on the NYSE under the symbol &#8220;OXY WS.&#8221; </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Occidental will receive proceeds from the exercise of the Warrants. See &#8220;Use of Proceeds&#8221; in this prospectus supplement. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;">Investing in our Common Stock involves risks. Please read &#8220;Risk Factors&#8221; in this prospectus supplement and in the accompanying prospectus and other information included or incorporated by reference into this prospectus supplement and the accompanying prospectus.<font style="font-weight: normal;"> </font></div><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 15.25pt;"> </div></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;">Neither the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.<font style="font-weight: normal;"> </font></div><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 15.25pt;"> </div></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 170.5pt; text-align: center;">The date of this prospectus supplement is March&#160;3, 2025. </div></div></div></div>
<!--End Page 1-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 2-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_101-toc_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">TABLE OF CONTENTS </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; text-align: center;">Prospectus Supplement </div><a name="TOC"><!--Anchor--></a><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468.89pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 444pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 18.89pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 444pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.89pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Page</div></td></tr><tr><td style="width: 444pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sATP">ABOUT THIS PROSPECTUS SUPPLEMENT<font style="padding-left: 3.56pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.89pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sATP"><font style="padding-left: 4.44pt;">S-ii </font></a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sFLS">FORWARD-LOOKING STATEMENTS<font style="padding-left: 2.89pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sFLS"><font style="padding-left: 1.66pt;">S-iii </font></a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sTO">THE OFFERING<font style="padding-left: 4.85pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sTO"><font style="padding-left: 5pt;">S-1 </font></a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sOPC">OCCIDENTAL PETROLEUM CORPORATION<font style="padding-left: 2.16pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sOPC"><font style="padding-left: 5pt;">S-2 </font></a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sRF">RISK FACTORS<font style="padding-left: 1.32pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sRF"><font style="padding-left: 5pt;">S-3 </font></a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sUOP">USE OF PROCEEDS<font style="padding-left: 2.07pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sUOP"><font style="padding-left: 5pt;">S-5 </font></a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sDOT">DESCRIPTION OF THE WARRANTS<font style="padding-left: 4.68pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sDOT"><font style="padding-left: 5pt;">S-6 </font></a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sVOS">VALIDITY OF SECURITIES<font style="padding-left: 4.31pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sVOS"><font style="padding-left: 0.37pt;">S-11 </font></a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sEX">EXPERTS<font style="padding-left: 3.77pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sEX"><font style="padding-left: 0.37pt;">S-11 </font></a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sWYC">WHERE YOU CAN FIND MORE INFORMATION<font style="padding-left: 0.84pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.89pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sWYC">S-12</a></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 444pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 18.89pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; text-align: center;">Prospectus </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 444pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 16.44pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 444pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.78pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Page</div></td></tr><tr><td style="width: 444pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tATP">ABOUT THIS PROSPECTUS<font style="padding-left: 1.33pt;"></font></a></div></td><td style="width: 3.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tATP"><font style="padding-left: 5pt;">1</font></a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tWYC">WHERE YOU CAN FIND MORE INFORMATION<font style="padding-left: 0.84pt;"></font></a></div></td><td style="width: 3.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tWYC"><font style="padding-left: 5pt;">2</font></a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tFLS">FORWARD-LOOKING STATEMENTS<font style="padding-left: 2.89pt;"></font></a></div></td><td style="width: 3.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tFLS"><font style="padding-left: 5pt;">3</font></a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tAOC">ABOUT OCCIDENTAL<font style="padding-left: 0.84pt;"></font></a></div></td><td style="width: 3.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tAOC"><font style="padding-left: 5pt;">5</font></a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tRF">RISK FACTORS<font style="padding-left: 1.32pt;"></font></a></div></td><td style="width: 3.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tRF"><font style="padding-left: 5pt;">5</font></a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tUOP">USE OF PROCEEDS<font style="padding-left: 2.07pt;"></font></a></div></td><td style="width: 3.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tUOP"><font style="padding-left: 5pt;">5</font></a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOS">DESCRIPTION OF SENIOR DEBT SECURITIES<font style="padding-left: 1.73pt;"></font></a></div></td><td style="width: 3.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tDOS"><font style="padding-left: 5pt;">6</font></a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOD">DESCRIPTION OF SUBORDINATED DEBT SECURITIES<font style="padding-left: 1.18pt;"></font></a></div></td><td style="width: 3.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tDOD">16</a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOC">DESCRIPTION OF COMMON STOCK<font style="padding-left: 0.06pt;"></font></a></div></td><td style="width: 3.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tDOC">26</a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOP">DESCRIPTION OF PREFERRED STOCK<font style="padding-left: 4.49pt;"></font></a></div></td><td style="width: 3.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tDOP">29</a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOW">DESCRIPTION OF WARRANTS<font style="padding-left: 2.27pt;"></font></a></div></td><td style="width: 3.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tDOW">31</a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDDS">DESCRIPTION OF DEPOSITARY SHARES<font style="padding-left: 4.93pt;"></font></a></div></td><td style="width: 3.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tDDS">32</a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDPC">DESCRIPTION OF STOCK PURCHASE CONTRACTS AND STOCK PURCHASE UNITS<font style="padding-left: 2.5pt;"></font></a></div></td><td style="width: 3.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tDPC">33</a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOU">DESCRIPTION OF UNITS<font style="padding-left: 2.64pt;"></font></a></div></td><td style="width: 3.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tDOU">34</a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tPOD">PLAN OF DISTRIBUTION<font style="padding-left: 0.98pt;"></font></a></div></td><td style="width: 3.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tPOD">35</a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tLM">LEGAL MATTERS<font style="padding-left: 0.22pt;"></font></a></div></td><td style="width: 3.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tLM">36</a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tE">EXPERTS<font style="padding-left: 3.77pt;"></font></a></div></td><td style="width: 3.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tE">36</a></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 444pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 16.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-i<br></div></div></div>
<!--End Page 2-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 3-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_102-about_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="sATP"><!--Anchor--></a>ABOUT THIS PROSPECTUS SUPPLEMENT </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">You should rely only on the information contained in or incorporated by reference into this prospectus supplement and the accompanying prospectus and any applicable free writing prospectuses. We have not authorized any person to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. This prospectus supplement, the accompanying prospectus and any applicable free writing prospectus do not constitute an offer to sell or the solicitation of an offer to buy any securities other than the securities described in this prospectus supplement or an offer to sell or the solicitation of an offer to buy those securities in any circumstances or jurisdiction in which such offer or solicitation is unlawful. The information contained in this prospectus supplement and the accompanying prospectus is accurate only as of the respective dates on the front covers of this prospectus supplement and the accompanying prospectus, the information contained in any related free writing prospectus will be accurate only as of the date of that document, and the information contained in any document incorporated by reference into this prospectus supplement is accurate only as of the date of such document. Our business, financial condition, results of operations and prospects may have changed since those respective dates. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Unless otherwise expressly stated or the context otherwise requires, references to &#8220;dollars,&#8221; &#8220;$&#8221; and other similar references in this prospectus supplement, the accompanying prospectus and any related free writing prospectuses are to U.S. dollars. Unless otherwise expressly stated or the context otherwise requires, the words &#8220;Occidental,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; as used in this prospectus supplement refer to Occidental Petroleum Corporation and its subsidiaries. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-ii<br></div></div></div>
<!--End Page 3-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 4-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_103-fls_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="sFLS"><!--Anchor--></a>FORWARD-LOOKING STATEMENTS </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">This prospectus supplement, the accompanying prospectus and the documents incorporated by reference herein and therein contain forward-looking statements that involve risks and uncertainties that could materially affect expected results of operations, liquidity, cash flows and business prospects. Actual outcomes or results may differ from anticipated results, sometimes materially. Forward-looking and other statements regarding our sustainability efforts and aspirations are not an indication that these statements are necessarily material to investors or require disclosure in our filings with the SEC. In addition, historical, current and forward-looking sustainability-related statements may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve and definitions, assumptions, data sources and estimates or measurements that are subject to change in the future, including through rulemaking or guidance. Factors that could cause results to differ from those projected or assumed in any forward-looking statement include, but are not limited to: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">general economic conditions, including slowdowns and recessions, domestically or internationally; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our indebtedness and other payment obligations, including the need to generate sufficient cash flows to fund operations; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to successfully monetize select assets and repay or refinance debt and the impact of changes in our credit ratings or future increases in interest rates; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">assumptions about energy markets; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">global and local commodity and commodity-futures pricing fluctuations and volatility; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">supply and demand considerations for, and the prices of, our products and services; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">actions by the Organization of the Petroleum Exporting Countries (&#8220;OPEC&#8221;) and non-OPEC oil producing countries; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">results from operations and competitive conditions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">future impairments of our proved and unproved oil and gas properties or equity investments, or write-downs of productive assets, causing charges to earnings; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">unexpected changes in costs; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">inflation, its impact on markets and economic activity and related monetary policy actions by governments in response to inflation; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">availability of capital resources, levels of capital expenditures and contractual obligations; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the regulatory approval environment, including our ability to timely obtain or maintain permits or other government approvals, including those necessary for drilling and/or development projects; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to successfully complete, or any material delay of, field developments, expansion projects, capital expenditures, efficiency projects, acquisitions or divestitures; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">risks associated with acquisitions, mergers and joint ventures, such as difficulties integrating businesses, uncertainty associated with financial projections or projected synergies, restructuring, increased costs and adverse tax consequences; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">uncertainties and liabilities associated with acquired and divested properties and businesses; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">uncertainties about the estimated quantities of oil, natural gas liquids (&#8220;NGL&#8221;) and natural gas reserves; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">lower-than-expected production from development projects or acquisitions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to realize the anticipated benefits from prior or future streamlining actions to reduce fixed&#160;costs, simplify or improve processes and improve our competitiveness; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">exploration, drilling and other operational risks; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">disruptions to, capacity constraints in, or other limitations on the pipeline systems that deliver our oil and natural gas and other processing and transportation considerations; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-iii<br></div></div></div>
<!--End Page 4-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 5-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_103-fls_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">volatility in the securities, capital or credit markets, including capital market disruptions and instability of financial institutions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">government actions (including geopolitical, trade, tariff and regulatory uncertainties), war (including the Russia-Ukraine war and conflicts in the Middle East) and political conditions and events; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">health, safety and environmental (&#8220;HSE&#8221;) risks, costs and liability under existing or future federal, regional, state, provincial, tribal, local and international HSE laws, regulations and litigation (including related to climate change or remedial actions or assessments); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">legislative or regulatory changes, including changes relating to hydraulic fracturing or other oil and natural gas operations, retroactive royalty or production tax regimes and deep-water and onshore drilling and permitting regulations; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to recognize intended benefits from our business strategies and initiatives, such as our low-carbon ventures businesses or announced greenhouse gas emissions (&#8220;GHG&#8221;) reduction targets or net-zero goals; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">potential liability resulting from pending or future litigation, government investigations and other proceedings; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">disruption or interruption of production or manufacturing or facility damage due to accidents, chemical releases, labor unrest, weather, power outages, natural disasters, cyber-attacks, terrorist acts or insurgent activity; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the scope and duration of global or regional health pandemics or epidemics, and actions taken by government authorities and other third parties in connection therewith; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the creditworthiness and performance of our counterparties, including financial institutions, operating partners and other parties; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">failure of risk management; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to retain and hire key personnel; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">supply, transportation and labor constraints; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reorganization or restructuring of our operations; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">changes in state, federal or international tax rates; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">actions by third parties that are beyond our control. </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Words such as &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;predict,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;anticipate,&#8221; &#8220;plan,&#8221; &#8220;intend,&#8221; &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;aim,&#8221; &#8220;goal,&#8221; &#8220;target,&#8221; &#8220;objective,&#8221; &#8220;commit,&#8221; &#8220;advance,&#8221; &#8220;likely&#8221; or similar expressions that convey the prospective nature of events or outcomes are generally indicative of forward-looking statements. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this prospectus supplement or, in the case of documents incorporated by reference, as of the date of those documents. Unless legally required, we undertake no obligation to update, modify or withdraw any forward-looking statements, as a result of new information, future events or otherwise. Material risks that may affect our results of operations and financial position appear under the heading &#8220;Risk Factors&#8221; and elsewhere in this prospectus supplement, the accompanying prospectus and our most recent Annual Report on Form&#160;10-K, which is incorporated herein by reference, as well as in any of our subsequently-filed annual, quarterly or current reports that are incorporated by reference in this prospectus supplement and the accompanying prospectus. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-iv<br></div></div></div>
<!--End Page 5-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 6-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20044010x1_424b2_104-summary_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="sTO"><!--Anchor--></a>THE OFFERING </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 6pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Common Stock to be issued, assuming full exercise of all outstanding Warrants<font style="font-weight: normal; padding-left: 4.13pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: left;">74,020,695 shares of Common Stock </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 6pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Proceeds, assuming full exercise of all outstanding Warrants<font style="font-weight: normal; padding-left: 0.69pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: left;">Approximately $1.63&#160;billion (initial exercise price of $22.00 per share) </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">NYSE Listing for the Common Stock<font style="font-weight: normal; padding-left: 2.96pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: left;">&#8220;OXY&#8221; </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">NYSE Listing for the Warrants<font style="font-weight: normal; padding-left: 4.68pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: left;">&#8220;OXY WS&#8221; </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Aggregate number of Warrants outstanding<font style="font-weight: normal; padding-left: 4.98pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: left;">74,020,695 (as of February&#160;24, 2025). </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Exercisability<font style="font-weight: normal; padding-left: 4.8pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: left;">Each Warrant is exercisable for one share of Common Stock, subject to adjustment. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Exercise Price<font style="font-weight: normal; padding-left: 2.05pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: left;">$22.00 per share, subject to adjustment. The Warrants require the payment of cash consideration. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Exercise Period<font style="font-weight: normal; padding-left: 1.93pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: left;">The Warrants are generally exercisable at any time until 5:00 p.m., New York City time, on August&#160;3, 2027 (or, if that date is not a business day, the next business day), subject to the terms and conditions set forth in the Warrant Agreement. In particular, the Warrants will be exercisable only if a registration statement relating to the Common Stock issuable upon exercise is effective and current.</div></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-1<br></div></div></div>
<!--End Page 6-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 7-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_105-corp_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="sOPC"><!--Anchor--></a>OCCIDENTAL PETROLEUM CORPORATION </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Occidental is an international energy company with premier diversified assets primarily located in the United States, the Middle East and North Africa. Occidental&#8217;s principal businesses consist of three reporting segments: oil and gas, chemical and midstream and marketing. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Corporate Information </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Occidental is incorporated in Delaware. Its principal executive offices are located at 5 Greenway Plaza, Suite&#160;110, Houston, Texas 77046 and its telephone number is (713) 215-7000. Occidental&#8217;s website address is <font style="font-style: italic;">www.oxy.com</font>. Information contained on Occidental&#8217;s website does not constitute part of this prospectus supplement. Occidental&#8217;s Common Stock is traded on the NYSE, under the ticker symbol &#8220;OXY.&#8221; Additional information about Occidental is included in documents incorporated by reference in this prospectus supplement. See &#8220;Where You Can Find More Information.&#8221; </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-2<br></div></div></div>
<!--End Page 7-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 8-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_106-risk_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="sRF"><!--Anchor--></a>RISK FACTORS </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;">Investing in our Common Stock involves risks. Before you invest in our Common Stock, you should carefully consider the following risk factors, in addition to the other information contained or incorporated by reference in this prospectus supplement and the accompanying prospectus. Specifically, please see &#8220;Risk Factors&#8221; included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2024, as such risks may be updated or supplemented in our subsequently filed Annual Reports on Form&#160;10-K, Quarterly Reports on Form&#160;10-Q or Current Reports on Form&#160;8-K, and the other information in that and the other reports that we file with the SEC&#160;that are incorporated by reference in this prospectus supplement or the accompanying prospectus for a discussion of risk factors that may affect the business.<font style="font-style: normal;"> </font></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; text-align: center;">Risks Related to Our Common Stock </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Our stock price may fluctuate significantly. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The market price of our Common Stock could vary significantly as a result of a number of factors, some of which are beyond our control. In the event of a drop in the market price of our Common Stock, you could lose a substantial part or all of your investment in our Common Stock. Among others, the following factors could affect our stock price: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our business performance and prospects; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">sales of our Common Stock, or the perception that such sales may occur, by us or by our stockholders; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">quarterly variations in the rates of growth of our operating and financial indicators, such as net income (loss) per share, net income (loss) and total revenue; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">changes in our dividend policy; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any failure to achieve near- or long-term goals we have publicly disclosed for our operating and financial performance; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the public reaction to our press releases, our other public announcements and our filings with the SEC; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">strategic actions by our competitors, such as acquisitions, restructurings, significant contracts, joint marketing relationships, joint ventures or capital commitments; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">introduction of new products and services by us or our competitors; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">announcements related to litigation; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our failure to meet revenue or earnings estimates made by research analysts or other investors; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">changes in revenue or earnings estimates, or changes in recommendations or withdrawal of research coverage, by equity research analysts; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">speculation in the press or investment community; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">changes in accounting principles, policies, guidance, interpretations or standards; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">additions or departures of key management personnel; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">actions by our stockholders; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">general market conditions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">domestic and international economic, legal and regulatory factors unrelated to our performance; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the realization of any risks described under this &#8220;Risk Factors&#8221; section, or other risks that may materialize in the future. </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The stock markets in general have experienced extreme volatility that has often been unrelated to the operating performance of particular companies. These broad market fluctuations may adversely affect the trading price of our Common Stock. Securities class action litigation has often been instituted against companies following periods of volatility in the overall market and in the market price of a company&#8217;s securities. Such litigation, if instituted against us, could result in substantial costs, divert our management&#8217;s attention and resources and have a material adverse effect on our business, financial condition, results of operations and cash flows. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-3<br></div></div></div>
<!--End Page 8-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 9-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_106-risk_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Our certificate of incorporation and applicable law could prevent a third party from acquiring us or limit the price that investors might be willing to pay for shares of our Common Stock. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Our amended and restated certificate of incorporation authorizes our board of directors (&#8220;Board&#8221;) to issue new series of preferred stock without stockholder approval. Depending on the rights and terms of any new series created, and the reaction of the market to the series, your rights or the value of your Common Stock could be negatively affected. For example, subject to applicable law, our Board could create a series of preferred stock with preferential rights to dividends or assets upon liquidation, or with superior voting rights to our existing Common Stock. The ability of our Board to issue these new series of preferred stock could also prevent or delay a third party from acquiring us, even if doing so would be beneficial to our stockholders. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">In addition, we are subject to the anti-takeover provisions of Section&#160;203 of the Delaware General Corporation Law (the &#8220;DGCL&#8221;), which prohibits Delaware corporations from engaging in certain business combinations with an interested stockholder (generally, a 15% or greater stockholder) for a period of three years after the date of the transaction in which the person first becomes an interested stockholder, unless: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the business combination is approved in advance by a majority of the independent directors; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of our voting stock; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the business combination is approved by our Board and by the holders of at least two-thirds of the outstanding shares of our Common Stock that is not owned by the interested stockholder. </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The application of Section&#160;203 of the DGCL could have the effect of delaying or preventing a change of control of us. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Future sales of shares by us or our existing stockholders could cause our stock price to decline. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Sales of substantial amounts of our Common Stock in the public market, or the perception that these sales could occur, could cause the market price of our Common Stock to decline. These sales, or the possibility that these sales may occur, also might make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">If securities or industry analysts do not publish research or publish misleading or unfavorable research about our business, our Common Stock price and trading volume could decline. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The trading market for our Common Stock depends in part on the research and reports that securities or industry analysts may publish about us or our business. If one or more of the analysts that covers our Common Stock downgrades our stock or publishes misleading or unfavorable research about our business, our stock price would likely decline. If one or more of the analysts ceases coverage of our Common Stock or fails to publish reports on us regularly, demand for our Common Stock could decrease, which could cause our Common Stock price or trading volume to decline. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-4<br></div></div></div>
<!--End Page 9-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 10-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_107-use_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="sUOP"><!--Anchor--></a>USE OF PROCEEDS </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We will receive the proceeds from the sale by us of shares of our Common Stock to holders of Warrants upon exercise of the relevant Warrants. In the event that all of the Warrants outstanding are exercised by the holders thereof at the initial exercise price of $22.00 per share, Occidental would receive proceeds of approximately $1.63&#160;billion. Holders of the Warrants are not obligated to exercise the Warrants, and the Warrants might never be exercised. Accordingly, there is no guarantee that Occidental will receive any proceeds related to the Warrants. Occidental expects that it will use the proceeds from the exercise of the Warrants, if any, for general corporate purposes. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-5<br></div></div></div>
<!--End Page 10-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 11-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_108-description_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="sDOT"><!--Anchor--></a>DESCRIPTION OF THE WARRANTS </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The Warrants have been issued by Occidental pursuant to the Warrant Agreement. The following description of the Warrants and the Warrant Agreement is only a brief summary and is qualified in its entirety by reference to the complete description of the terms of the Warrants set forth in the Warrant Agreement (including the Form&#160;of Warrant attached thereto), which has been filed as an exhibit to our Current Report on Form&#160;8-K, filed on July&#160;27, 2020. Occidental has caused the Warrants to be listed on the NYSE for trading under the symbol &#8220;OXY WS.&#8221; As of February&#160;24, 2025, 74,020,695 of the Warrants remain outstanding. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Each Warrant represents the right to purchase from Occidental one share of Common Stock for cash at an initial exercise price of $22.00 per share, payable in U.S. dollars (subject to adjustment as described under &#8220;Anti-dilution Adjustments&#8221; below). The Warrants will expire on August&#160;3, 2027 (or if that date is not a Business Day (as defined below), the next Business Day) (the &#8220;Expiration Date&#8221;). Occidental has issued the Warrants in uncertificated, direct registration form. The Warrant Agent will not be required to effect any registration of transfer or exchange that would result in the issuance of a Warrant Certificate or book-entry position for a fraction of a Warrant. Warrant holders will not be entitled to receive physical certificates. Registration of ownership will be maintained by the Warrant Agent. Occidental will at all times reserve for issuance the aggregate number of shares of Common Stock for which the Warrants may be exercised. The Warrants will not be redeemable by Occidental. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">All or any part of the Warrants may be exercised prior to 5:00 p.m., New York City time, on any Business Day (each day that is not a Saturday, a Sunday or a day on which banking institutions are not required to be open in the State of New York) on or prior to the Expiration Date by delivering a completed form of election to purchase Common Stock and payment of the then-current exercise price in cash to the Warrant Agent. Any such delivery that occurs on a day that is not a Business Day or is received after 5:00 p.m., New York City time, on any given Business Day will be deemed received and exercised on the next succeeding Business Day. Upon such delivery, Occidental has issued such whole number of shares of Common Stock as the exercising Warrant holder is entitled to receive, and will pay or cause to be paid to such Warrant holder cash in lieu of fractional shares of Common Stock (without interest and computed to the nearest cent) otherwise issuable in connection with the exercise of the Warrant. The shares of Common Stock issuable upon exercise will be issued by Equiniti Trust Company, Occidental&#8217;s transfer agent, through Occidental&#8217;s direct registration system for the account of the exercising Warrant holder. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The Warrant Agreement may be amended without the consent of any Warrant holder for the purpose of curing any ambiguity or curing, correcting or supplementing any defective or inconsistent provision, or for the purpose of adding or changing any other provisions, including, but not limited to, additions or changes with respect to matters or questions arising under the Warrant Agreement. The consent of a majority in interest of the then-outstanding Warrants is required for any amendment that materially and adversely affects the interests of the holders of the then-outstanding Warrants. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">A holder of unexercised Warrants, in his or her capacity as such, is not entitled to any rights of a holder of Common Stock, including, without limitation, the right to vote or to receive dividends or other distributions. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Occidental has agreed in the Warrant Agreement to use commercially reasonable efforts to cause a shelf registration statement (including, at Occidental&#8217;s election, an existing registration statement), filed pursuant to Rule&#160;415 (or any successor provision) of the Securities Act, covering the issuance of Common Stock to the Warrant holders upon exercise of the Warrants to remain effective until the earlier of (i) such time as all Warrants have been exercised and (ii) the Expiration Date. Occidental may suspend the availability of the registration statement relating to the Warrants from time to time for a maximum of 45 days in a given 365-day period, if the Board determines that such a suspension would be necessary to comply with applicable laws and Occidental provides notice to the Warrant holders. If the registration is so suspended in the 45 days prior to the Expiration Date, the Expiration Date will be delayed for a number of days equal to the number of days during such 45-day period that the registration statement was suspended. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The Warrants are exercisable only if there is an effective shelf registration statement, filed pursuant to Rule&#160;415 (or any successor provision) under the Securities Act, registering the issuance of Common Stock upon exercise that is not subject to suspension pursuant to the Warrant Agreement, and only if the shares of Common Stock issuable upon exercise are qualified for sale or exempt from qualification under the applicable securities laws of any relevant states or other jurisdictions. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-6<br></div></div></div>
<!--End Page 11-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 12-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_108-description_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">All expenses related to the registration and approval of the Common Stock issuable upon exercise of the Warrants will be borne by Occidental. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Anti-dilution Adjustments </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The exercise price and number of shares of Common Stock issuable upon exercise of a Warrant will be subject to adjustment, without duplication, as follows, except that Occidental will not make any such adjustments if each Warrant holder participates, at the same time and upon the same terms as holders of the Common Stock and solely as a result of holding the Warrants, in any of the transactions described below, without having to exercise such Warrant holder&#8217;s Warrants, as if such Warrant holder held a number of shares of Common Stock equal to the number of shares of Common Stock issuable upon exercise of such Warrant holder&#8217;s Warrants: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">If Occidental (i) declares and pays a dividend or makes a distribution on its Common Stock in shares of Common Stock, (ii) subdivides or reclassifies the outstanding shares of Common Stock into a greater number of shares or (iii) combines or reclassifies the outstanding shares of Common Stock into a smaller number of shares then, in such event: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the number of shares of Common Stock issuable upon exercise of a Warrant on the record date for such dividend or distribution or the effective date of such subdivision, combination or reclassification will be proportionately adjusted so that the Warrant holder after such date will be entitled to purchase the number of shares of Common Stock that such Warrant holder would have owned or been entitled to receive in respect of the shares of Common Stock subject to such Warrant after such date had such Warrant been exercised immediately prior to such date; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the exercise price in effect on the record date for such dividend or distribution or the effective date of such subdivision, combination or reclassification will be adjusted to the number obtained by dividing (x) the product of (1) the number of shares of Common Stock issuable upon exercise of the Warrant before such adjustment and (2) the exercise price in effect immediately prior to the record or effective date, as the case may be, for the dividend, distribution, subdivision, combination or reclassification giving rise to the adjustment by (y) the new number of shares of Common Stock issuable upon exercise of the Warrant determined pursuant to clause (1) above. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(b)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">If Occidental issues shares of Common Stock (or rights or warrants or other securities exercisable or convertible into or exchangeable (collectively, a &#8220;conversion&#8221;) for shares of Common Stock (collectively, &#8220;convertible securities&#8221;)) (other than in Permitted Transactions (as defined below) or a transaction to which clause (a) above or clauses (c) or (d) below apply) without consideration or at a consideration per share in the case of Common Stock (or, in the case of rights, warrants or other securities, having a conversion price per share) that is less than 95% of the Market Price (as defined in the Warrant Agreement) on the last Trading Day (as defined in the Warrant Agreement) preceding the date on which the relevant sales price, conversion price or exercise price is established then, in such event: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the number of shares of Common Stock issuable upon exercise of a Warrant immediately prior to the date on which the sales price, conversion price or exercise price is established (the &#8220;Initial Number&#8221;) will be increased to the number obtained by multiplying the Initial Number by a fraction (a) the numerator of which will be the sum of (x) the number of shares of Common Stock of Occidental outstanding on such date and (y) the number of additional shares of Common Stock issued (or into which convertible securities may be exercised or convert) and (b) the denominator of which will be the sum of (x) the number of shares of Common Stock outstanding on such date and (y) the number of shares of Common Stock that the aggregate consideration receivable by Occidental for the total number of shares of Common Stock so issued (or into which convertible securities may be exercised or convert) would purchase at the Market Price on the last Trading Day preceding the date on which the sales price, conversion price or exercise price is established; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the exercise price payable upon exercise of a Warrant will be adjusted by multiplying such exercise price in effect immediately prior to the date on which the sales price, conversion price or exercise price is established by a fraction, the numerator of which will be the number of shares of Common Stock issuable upon exercise of such Warrant prior to such date and the denominator of which will be the number of shares of Common Stock issuable upon exercise of such Warrant immediately after the adjustment described in paragraph (1) above. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-7<br></div></div></div>
<!--End Page 12-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 13-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_108-description_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">For purposes of the foregoing, the aggregate consideration receivable by Occidental in connection with the issuance of such shares of Common Stock or convertible securities will be deemed to be equal to the sum of the net offering price (after deduction of any related expenses payable to third parties) of all such securities plus the minimum aggregate amount, if any, payable upon exercise or conversion of any such convertible securities into shares of Common Stock; and &#8220;Permitted Transactions&#8221; will include issuances (1) as consideration for or to fund the acquisition by Occidental of businesses and/or assets constituting a significant part of a business, (2) in connection with employee benefit plans and compensation related arrangements of Occidental approved by the Board, (3) in connection with a broadly marketed offering and sale of Common Stock or convertible securities for cash and (4) upon exercise of rights, warrants or other securities exercisable or convertible into or exchangeable for shares of Common Stock outstanding on the date of the Warrant Agreement or in accordance with the terms (whether mandatory or optional) of any security, instrument or agreement outstanding or in effect on the date of the Warrant Agreement. Any adjustment made pursuant to clause (b) above will become effective immediately upon the date of such issuance. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(c)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">If Occidental fixes a record date for the making of a distribution to all holders of shares of its Common Stock of securities, evidences of indebtedness, assets, cash, rights or warrants (excluding (x) Ordinary Cash Dividends (as defined in the Warrant Agreement) and (y) dividends of its Common Stock and other dividends or distributions referred to in clause (a) above or clause (e) below), then, in each case: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the exercise price in effect prior to such record date will be reduced immediately thereafter to the price determined by multiplying the exercise price in effect immediately prior to the reduction by the quotient of (x) the Market Price of the Common Stock on the last Trading Day preceding the first date on which the Common Stock trades regular way on the NYSE without the right to receive such distribution, minus the amount of cash or the Fair Market Value (as defined in the Warrant Agreement) of the securities, evidences of indebtedness, assets, rights or warrants to be so distributed in respect of one share of Common Stock (the &#8220;Per Share Fair Market Value&#8221;) divided by (y) such Market Price on such date specified in clause (x); such adjustment will be made successively whenever such a record date is fixed; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the number of shares of Common Stock issuable upon exercise of each Warrant will be increased to the number obtained by dividing (x) the product of (1) the number of shares of Common Stock issuable upon exercise of each Warrant before such adjustment, and (2) the exercise price in effect immediately prior to the distribution giving rise to this adjustment by (y) the new exercise price determined in accordance with paragraph (1) above. </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">In the case of adjustment for a cash dividend that is, or is coincident with, a quarterly dividend, the Per Share Fair Market Value will be reduced by the per share amount of the portion of the cash dividend that would constitute an Ordinary Cash Dividend. In the event that such distribution is not so made, the exercise price and the number of shares of Common Stock issuable upon exercise of each Warrant then in effect will be readjusted, effective as of the date when the Board determines not to distribute such shares, evidences of indebtedness, assets, rights, cash or warrants, as the case may be, to the exercise price that would then be in effect and the number of shares of Common Stock issuable upon exercise of each Warrant that would then be issuable upon exercise of each Warrant if such record date had not been fixed. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(d)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">If Occidental effects a Pro Rata Repurchase (as defined in the Warrant Agreement) of Common Stock, then: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the exercise price will be adjusted to the price determined by multiplying the exercise price in effect immediately prior to the effective date of such Pro Rata Repurchase by a fraction of which the numerator will be (x) the product of (1) the number of shares of Common Stock outstanding immediately before such Pro Rata Repurchase and (2) the Market Price of a share of Common Stock on the Trading Day immediately preceding the first public announcement by Occidental or any of its affiliates of the intent to effect such Pro Rata Repurchase, minus (y) the aggregate purchase price of the Pro Rata Repurchase, and of which the denominator will be the product of (1) the number of shares of Common Stock outstanding immediately prior to such Pro Rata Repurchase minus the number of shares of Common Stock so repurchased and (2) the Market Price per share of Common Stock on the Trading Day immediately preceding the first public announcement by Occidental or any of its affiliates of the intent to effect such Pro Rata Repurchase; and </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-8<br></div></div></div>
<!--End Page 13-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 14-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_108-description_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the number of shares of Common Stock issuable upon exercise of each Warrant will be adjusted to the number obtained by dividing (x) the product of (1) the number of shares of Common Stock issuable upon exercise of such Warrant before such adjustment, and (2) the exercise price in effect immediately prior to the Pro Rata Repurchase giving rise to this adjustment by (y) the new exercise price determined in accordance with paragraph (1) above. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(e)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">(i) If Occidental distributes or is deemed to have distributed, or fixes a record date for the making of a distribution, to all holders of shares of its Common Stock of rights or warrants pursuant to a stockholder rights plan commonly known as a &#8220;poison pill&#8221; (a &#8220;Rights Plan&#8221;), which rights or warrants are not exercisable until the occurrence of a specified event or events (a &#8220;Trigger Event&#8221;), in each such case, upon the occurrence of the earliest such Trigger Event, the exercise price in effect prior to such Trigger Event will be reduced immediately after such Trigger Event to the price determined by multiplying the exercise price in effect immediately prior to the reduction by the quotient of (i)&#160;the Market Price of the Common Stock on the last Trading Day preceding the date of such Trigger Event (or, if the occurrence of such Trigger Event is not publicly disclosed as of the date of such Trigger Event, the last Trading Day preceding the first date on which the occurrence of such Trigger Event is publicly disclosed) (either such date, as applicable, the &#8220;Pre-Trigger Event Date&#8221;), minus the Fair Market Value of the rights or warrants distributed in respect of one share of Common Stock (determined as of the date of such Trigger Event or public disclosure of such Trigger Event, as applicable, after giving effect to the occurrence of such Trigger Event), divided by (ii) such Market Price on the Pre-Trigger Event Date; such adjustment will be made successively whenever any Trigger Event occurs under any Rights Plan and, with respect to any Rights Plan with respect to which an adjustment has been made, a corresponding adjustment will be made successively whenever any subsequent adjustment to the applicable rights or warrants is made pursuant to the terms of such Rights Plan to the extent such adjustment has not been made pursuant to the other terms of the Warrants. In such event, the number of shares of Common Stock issuable upon exercise of each Warrant will be increased to the number obtained by dividing (x) the product of (1) the number of shares of Common Stock issuable upon exercise of each Warrant before such adjustment, and (2) the exercise price in effect immediately prior to the applicable Trigger Event or subsequent adjustment by (y) the new exercise price determined in accordance with the immediately preceding sentence. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(ii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">In the event of any distribution (or deemed distribution) of rights or warrants, or any Trigger Event with respect thereto described in clause (e)(i) above: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 60pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">upon the redemption or repurchase by Occidental of any such rights or warrants without exercise by the holders thereof, (x) in the event that a Trigger Event will have occurred and an adjustment to the Exercise Price and number of shares of Common Stock issuable upon exercise of each Warrant will have been made pursuant to clause (e)(i) above, the exercise price and number of shares of Common Stock issuable upon exercise of such Warrant will be readjusted as if such rights or warrants had not been distributed, and (y) whether or not a Trigger Event will have occurred, the exercise price and the number of shares of Common Stock issuable upon exercise of such Warrant will be adjusted or readjusted, as applicable, pursuant to the terms of clause (c) above upon such redemption or repurchase as though it were a cash distribution (but not an Ordinary Cash Dividend) equal to the per share redemption or repurchase consideration received by holders of shares of Common Stock with respect to such rights or warrants (assuming such holder had retained such rights or warrants) made to all holders of shares of Common Stock as of the date of such redemption or repurchase, it being understood that if a readjustment has occurred pursuant to clause (x)&#160;above, the readjustment described in this clause (y) will occur immediately following such readjustment made pursuant to clause (x); and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 60pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">in the event that a Trigger Event will have occurred and an adjustment to the exercise price and number of shares of Common Stock issuable upon exercise of each Warrant will have been made pursuant to clause (e)(i) above, in the case all such rights or warrants will have expired or been terminated without exercise by any holders thereof, the exercise price and the number of shares of Common Stock issuable upon exercise of each Warrant will be readjusted as if such rights and warrants had not been distributed. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-9<br></div></div></div>
<!--End Page 14-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 15-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_108-description_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(iii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">If Occidental has a Rights Plan in effect with respect to its Common Stock, upon exercise of a Warrant, notwithstanding anything to the contrary in such Rights Plan, including any rights agreement or documents or instruments entered into as part of such Rights Plan, the Warrant holder will be entitled to receive, in addition to the shares of Common Stock issuable upon exercise of each Warrant, a corresponding number of rights under such Rights Plan, unless (A) a Trigger Event occurs prior to such exercise, in which case the adjustments (if any are required) to the exercise price and the number of shares of Common Stock issuable upon exercise of the Warrant with respect thereto will be made in accordance with clause (e)(i) above, or (B) the Warrant holder has provided written notice to Occidental that it has elected not to receive such rights. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(iv)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Any adjustment to the exercise price and the number of shares of Common Stock issuable upon exercise of each Warrant will be made subject in all respects to the other anti-dilution adjustment provisions of the Warrant Agreement (but without duplication); <font style="font-style: italic;">provided </font>that certain limitations, as described in the Warrant Agreement, apply. </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">In addition, Occidental may, but will not be required to, make such decreases in the exercise price, in addition to those required by the above provisions, as the Board considers to be advisable for any reason, including, without limitation, in order to avoid or diminish any income tax to any holders of shares of Common Stock or to any Warrant holders resulting from any dividend or distribution of stock or from any event treated as such for income tax purposes or for any other reason. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">All calculations made pursuant to the adjustment provisions described above will be made to the nearest one-tenth (1/10th) of a cent or to the nearest one-hundredth (1/100th) of a share, as the case may be. No adjustment in the exercise price or the number of shares of Common Stock into which a Warrant is exercisable will be made if the amount of such adjustment would be less than $0.01 or one-tenth (1/10th) of a share of Common Stock, but any such amount will be carried forward and an adjustment with respect thereto will be made at the time of and together with any subsequent adjustment that, together with such amount and any other amount or amounts so carried forward, will aggregate $0.01 or 1/10th of a share of Common Stock, or more. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">In any case in which the above provisions require that an adjustment become effective immediately after a record date for an event, Occidental may defer until the occurrence of such event (i) issuing to the holder of a Warrant exercised after such record date and before the occurrence of such event the additional shares of Common Stock issuable upon such exercise by reason of the adjustment required by such event over and above the shares of Common Stock issuable upon such exercise before giving effect to such adjustment and (ii) paying to such Warrant holder any amount of cash in lieu of a fractional share of Common Stock; <font style="font-style: italic;">provided, however</font>, that Occidental upon request will deliver to such Warrant holder a due bill or other appropriate instrument evidencing such Warrant holder&#8217;s right to receive such additional shares, and such cash, upon the occurrence of the event requiring such adjustment. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Any adjustments will be made successively whenever an event referred to above occurs. If an adjustment in exercise price made pursuant to the above provisions would reduce the exercise price to an amount below the par value of the Common Stock, then such adjustment will reduce the exercise price to the par value of the Common Stock. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Business Combinations and Reorganizations </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">In the event of a merger, consolidation, statutory share exchange or similar transaction that requires the approval of Occidental&#8217;s stockholders (a &#8220;Business Combination&#8221;) or reclassification of Common Stock, other than a reclassification of Common Stock referred to in &#8220;Anti-dilution Adjustments&#8221; above, the right of a Warrant holder to receive Common Stock upon exercise of a Warrant will be converted into the right to exercise a Warrant to acquire the number of shares of stock or other securities or property (including cash) that the Common Stock issuable (at the time of such Business Combination or reclassification) upon exercise of such Warrant immediately prior to such Business Combination or reclassification would have been entitled to receive upon consummation of such Business Combination or reclassification (the amount of such shares, other securities or property in respect of a share of Common Stock being herein referred to as a &#8220;Unit of Reference Property&#8221;). If the Business Combination causes the Common Stock to be converted into, or exchanged for, the right to receive more than a single type of consideration (determined based in part upon any form of stockholder election), then the composition of the Unit of Reference Property into which the Warrants will be exercisable will be deemed to be the weighted average of the types and amounts of consideration actually received by the holders of Common Stock per share of Common Stock. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-10<br></div></div></div>
<!--End Page 15-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 16-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_109-info_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="sVOS"><!--Anchor--></a>VALIDITY OF SECURITIES </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Cravath, Swaine &amp; Moore LLP, New York, New York, has issued an opinion in respect of the validity of the shares of Common Stock issuable upon exercise of the Warrants. </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;"><a name="sEX"><!--Anchor--></a>EXPERTS </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The consolidated financial statements of Occidental Petroleum Corporation and subsidiaries as of December&#160;31, 2024 and 2023, and for each of the years in the three-year period ended December&#160;31, 2024 and management&#8217;s assessment of the effectiveness of internal control over financial reporting as of December&#160;31, 2024 have been incorporated by reference herein in reliance upon the reports of KPMG LLP, independent registered public accounting firm, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Certain information with respect to the oil and gas reserves associated with Occidental&#8217;s oil and gas properties is confirmed in the process review letter of Ryder Scott Company, L.P., independent petroleum engineering consultants, and has been incorporated by reference herein, upon the authority of said firm as experts with respect to the matters covered by such process review letter and in giving such process review letter. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-11<br></div></div></div>
<!--End Page 16-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 17-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_109-info_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="sWYC"><!--Anchor--></a>WHERE YOU CAN FIND MORE INFORMATION </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We are subject to the information reporting requirements of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). In accordance with the Exchange Act, we file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC file number is 001-09210. The SEC maintains a website that contains reports, proxy statements and other information about issuers, like us, that file electronically with the SEC. The address of that site is www.sec.gov. Such reports, proxy statements and other information filed by us can also be read through the Investor Relations section of our website at www.oxy.com. Information on our website does not constitute part of, and is not incorporated by reference in, this prospectus supplement or the accompanying prospectus and should not be relied upon in connection with making any investment decision with respect to our Common Stock. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The SEC allows us to &#8220;incorporate by reference&#8221; the information that we file with the SEC. This permits us to disclose important information to you by referencing these filed documents. Any information referenced this way is considered part of this prospectus supplement, and any such information filed with the SEC subsequent to the date of this prospectus supplement will automatically be deemed to update and supersede this information. This prospectus supplement incorporates by reference the documents listed below that we have previously filed with the SEC. They contain important information about us and our financial condition. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Annual Report on Form&#160;10-K for the year ended <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/797468/000079746825000029/oxy-20241231.htm">December&#160;31, 2024</a>; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Portions of our Definitive Proxy Statement on Schedule 14A filed with the SEC on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/797468/000079746824000075/oxy-20240321.htm">March&#160;21, 2024</a> that are incorporated by reference into Part&#160;III of our Annual Report on Form&#160;10-K for the year ended <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/797468/000079746824000034/oxy-20231231.htm">December&#160;31, 2023</a>; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The description of Occidental Common Stock contained in the registration statement on Form&#160;8-B, dated June&#160;26, 1986 (as amended by Form&#160;8, dated December&#160;22, 1986, Form&#160;8, dated February&#160;3, 1988, Form&#160;8-B/A, dated July&#160;12, 1993, Form&#160;8-B/A, dated March&#160;21, 1994, and Form&#160;8-B/A, dated <a href="https://www.sec.gov/Archives/edgar/data/797468/0000950148-95-000693.txt">November&#160;2, 1995</a>, and including any amendment or report filed with the SEC for the purpose of updating this description). </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We also incorporate by reference all documents we may subsequently file with the SEC pursuant to Section&#160;13(a), 13(c), 14 or 15(d) of the Exchange Act from the date of this prospectus supplement until the termination of the offering or offerings to which this prospectus supplement relates. Information furnished under Items 2.02 or 7.01 (and corresponding information furnished under Item&#160;9.01 or included as an exhibit) in any past or future Current Report on Form&#160;8-K that we file with the SEC, unless otherwise expressly specified in such report, is not incorporated by reference in this prospectus supplement. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We will provide, without charge upon written or oral request, a copy of any or all of the documents which are incorporated by reference into this prospectus supplement. Requests should be directed to: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; text-align: center;">Occidental Petroleum Corporation <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">5 Greenway Plaza, Suite 110 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Houston, Texas 77046 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Attn: Corporate Secretary <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Telephone: (713) 215-7000 </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-12<br></div></div></div>
<!--End Page 17-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 18-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 456pt;"><a name="ny20044010x1_424b2_201-cov_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 456pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Prospectus</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 56.25pt; text-align: center;"><img style="height: 109px; width: 107px;" src="logo_oxy2.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;">Senior Debt Securities<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">&#8195;<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Subordinated Debt Securities<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Common Stock<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">&#8195;<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Preferred Stock<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Warrants<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Depositary Shares<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock Purchase Contracts<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">&#8195;<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock Purchase Units<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Units</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 36pt; margin-left: 0pt; text-align: left;">Occidental Petroleum Corporation may offer from time to time an indeterminate number of our senior debt securities, subordinated debt securities, common stock, preferred stock, warrants, depositary shares, stock purchase contracts, stock purchase units and units. We refer to our senior debt securities, subordinated debt securities, common stock, preferred stock, warrants, depositary shares, stock purchase contracts, stock purchase units and units collectively as the &#8220;securities&#8221; in this prospectus. The securities we may offer may be convertible into or exercisable or exchangeable for other securities. This prospectus describes the general terms of these securities and the general manner in which we will offer these securities. We will provide the specific terms of the securities in supplements to this prospectus. You should read this prospectus and any supplement carefully before you invest.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 12pt; margin-left: 0pt; text-align: left;">Occidental Petroleum Corporation common stock is traded on the New York Stock Exchange under the trading symbol &#8220;OXY.&#8221;</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; text-align: center;">Investing in these securities involves risk. See &#8220;Risk Factors&#8221; beginning on page <a href="#tRF">5</a> of this prospectus.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Neither the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 148.5pt; text-align: center;">The date of this prospectus is July&#160;29, 2022.</div></div></div></div>
<!--End Page 18-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 19-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_202-toc_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">TABLE OF CONTENTS</div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 444pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 10pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 444pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tATP">ABOUT THIS PROSPECTUS<font style="padding-left: 1.33pt;"></font></a></div></td><td style="width: 7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tATP"><font style="padding-left: 5pt;">1</font></a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tWYC">WHERE YOU CAN FIND MORE INFORMATION<font style="padding-left: 0.84pt;"></font></a></div></td><td style="width: 7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tWYC"><font style="padding-left: 5pt;">2</font></a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tFLS">FORWARD-LOOKING STATEMENTS<font style="padding-left: 2.89pt;"></font></a></div></td><td style="width: 7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tFLS"><font style="padding-left: 5pt;">3</font></a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tAOC">ABOUT OCCIDENTAL<font style="padding-left: 0.84pt;"></font></a></div></td><td style="width: 7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tAOC"><font style="padding-left: 5pt;">5</font></a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tRF">RISK FACTORS<font style="padding-left: 1.32pt;"></font></a></div></td><td style="width: 7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tRF"><font style="padding-left: 5pt;">5</font></a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tUOP">USE OF PROCEEDS<font style="padding-left: 2.07pt;"></font></a></div></td><td style="width: 7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tUOP"><font style="padding-left: 5pt;">5</font></a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOS">DESCRIPTION OF SENIOR DEBT SECURITIES<font style="padding-left: 1.73pt;"></font></a></div></td><td style="width: 7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOS"><font style="padding-left: 5pt;">6</font></a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOD">DESCRIPTION OF SUBORDINATED DEBT SECURITIES<font style="padding-left: 1.18pt;"></font></a></div></td><td style="width: 7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOD">16</a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOC">DESCRIPTION OF COMMON STOCK<font style="padding-left: 0.06pt;"></font></a></div></td><td style="width: 7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOC">26</a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOP">DESCRIPTION OF PREFERRED STOCK<font style="padding-left: 4.49pt;"></font></a></div></td><td style="width: 7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOP">29</a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOW">DESCRIPTION OF WARRANTS<font style="padding-left: 2.27pt;"></font></a></div></td><td style="width: 7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOW">31</a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDDS">DESCRIPTION OF DEPOSITARY SHARES<font style="padding-left: 4.93pt;"></font></a></div></td><td style="width: 7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDDS">32</a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDPC">DESCRIPTION OF STOCK PURCHASE CONTRACTS AND STOCK PURCHASE UNITS<font style="padding-left: 2.5pt;"></font></a></div></td><td style="width: 7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDPC">33</a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOU">DESCRIPTION OF UNITS<font style="padding-left: 2.64pt;"></font></a></div></td><td style="width: 7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOU">34</a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tPOD">PLAN OF DISTRIBUTION<font style="padding-left: 0.98pt;"></font></a></div></td><td style="width: 7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tPOD">35</a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tLM">LEGAL MATTERS<font style="padding-left: 0.22pt;"></font></a></div></td><td style="width: 7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tLM">36</a></div></td></tr><tr><td style="width: 444pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tE">EXPERTS<font style="padding-left: 3.77pt;"></font></a></div></td><td style="width: 7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tE">36</a></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 444pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">i<br></div></div></div>
<!--End Page 19-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 20-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_203-about_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tATP"><!--Anchor--></a>ABOUT THIS PROSPECTUS</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Unless otherwise stated or the context otherwise requires, the terms &#8220;Occidental,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Occidental Petroleum Corporation and its subsidiaries. In the &#8220;Description of Senior Debt Securities,&#8221; &#8220;Description of Subordinated Debt Securities,&#8221; &#8220;Description of Common Stock,&#8221; &#8220;Description of Preferred Stock,&#8221; &#8220;Description of Warrants,&#8221; &#8220;Description of Depositary Shares,&#8221; &#8220;Description of Stock Purchase Contracts and Stock Purchase Units&#8221; and &#8220;Description of Units&#8221; sections of this prospectus, however, references to &#8220;Occidental,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer only to Occidental Petroleum Corporation and not to any of its subsidiaries.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">This prospectus is part of a registration statement that we have filed with the SEC using a &#8220;shelf&#8221; registration process. Using this process, we may offer any combination of the securities described in this prospectus in one or more offerings in amounts to be determined at the time of any offering. This prospectus provides you with a general description of the securities we may offer. Each time we use this prospectus to offer or sell securities, we will provide a prospectus supplement and, if applicable, a pricing supplement that will describe the specific terms of the offering. The prospectus supplement and any pricing supplement may add to, update or change the information contained in this prospectus. Please carefully read this prospectus, the accompanying prospectus supplement and any pricing supplement, in addition to the information contained in the documents we refer to under the heading &#8220;Where You Can Find More Information.&#8221;</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">1<br></div></div></div>
<!--End Page 20-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 21-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_203-about_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tWYC"><!--Anchor--></a>WHERE YOU CAN FIND MORE INFORMATION</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Occidental files annual, quarterly and current reports, proxy statements and other information with the SEC. You may access this information at the SEC&#8217;s internet website that contains reports, proxy statements and other information regarding issuers, including Occidental, who file electronically with the SEC. The address of that site is <font style="font-style: italic;">www.sec.gov</font>. The information contained on the SEC&#8217;s website is not incorporated by reference into this prospectus.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The SEC allows us to &#8220;incorporate by reference&#8221; certain information into this prospectus from certain documents that we file with the SEC prior to the date of this prospectus. By incorporating by reference, we are disclosing important information to you by referring you to documents that we have filed with the SEC. The information incorporated by reference is deemed to be part of this prospectus, except for information incorporated by reference that is modified or superseded by information contained in this prospectus or in a subsequently filed document that also is incorporated by reference herein. Any statement so modified or superseded will not be deemed, except as so modified or superseded, to be part of this prospectus. These documents contain important information about us and our business.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We are incorporating by reference into this prospectus the following documents filed with the SEC, excluding any document or portion thereof deemed to be &#8220;furnished&#8221; but not &#8220;filed&#8221; for purposes of the Exchange Act:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Annual report on Form 10-K for the year ended <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/797468/000079746822000008/oxy-20211231.htm">December&#160;31, 2021</a>;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Quarterly report on Form 10-Q for the quarter ended <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/797468/000079746822000018/oxy-20220331.htm">March&#160;31, 2022</a>;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Current reports on Form 8-K filed on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/797468/000114036122008070/brhc10034864_8k.htm">March&#160;7, 2022</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/797468/000114036122010740/brhc10035568_8k.htm">March&#160;23, 2022</a> and <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/797468/000114036122018654/brhc10037516_8k.htm">May&#160;11, 2022</a>; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The description of Occidental common stock contained in the registration statement on Form 8-B, dated June&#160;26, 1986 (as amended by Form 8, dated December&#160;22, 1986, Form 8, dated February&#160;3, 1988, Form 8-B/A, dated July&#160;12, 1993, Form 8-B/A, dated March&#160;21, 1994 and Form 8-B/A, dated <a href="https://www.sec.gov/Archives/edgar/data/797468/0000950148-95-000693.txt">November&#160;2, 1995</a>, and including any amendment or report filed with the SEC for the purpose of updating this description).</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We also incorporate by reference all documents we may subsequently file with the SEC pursuant to Section&#160;13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), from the date of this prospectus until the termination of each offering under this prospectus.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Information furnished under Item 2.02 or 7.01 (or corresponding information furnished under Item 9.01 or included as an exhibit) in any past or future current report on Form 8-K (including the current reports on Form&#160;8-K listed above) that we file with the SEC, unless otherwise expressly specified in such report, is not incorporated by reference into this prospectus.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">You can obtain any of the documents listed above from the SEC&#8217;s website at the address indicated above, or from Occidental by requesting them in writing or by telephone as follows:</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8pt; text-align: center;">Occidental Petroleum Corporation<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Attention: Corporate Secretary<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">5 Greenway Plaza, Suite 110<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Houston, Texas 77046 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Telephone: (713) 215-7000</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">These documents are available from Occidental without charge, excluding any exhibits to them unless the exhibit is specifically listed as an exhibit to the registration statement of which this prospectus forms a part. You can also find information about Occidental at our internet website at <font style="font-style: italic;">www.oxy.com</font>. Information contained on this website does not constitute part of this prospectus.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">You should rely only on the information contained or incorporated by reference into this prospectus, the prospectus supplement or any pricing supplement as having been authorized by us. We have not authorized any person, including any salesperson or broker, to provide information other than that provided in this prospectus, the prospectus supplement or any pricing supplement. We have not authorized anyone to provide you with different information. We are not making an offer of the securities in any jurisdiction where the offer is not permitted. You should assume that the information in this prospectus and any prospectus supplement or pricing supplement is accurate only as of the date on its cover page and that any information we have incorporated by reference herein or therein is accurate only as of the date of the document incorporated by reference.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">2<br></div></div></div>
<!--End Page 21-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 22-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_204-fls_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tFLS"><!--Anchor--></a>FORWARD-LOOKING STATEMENTS</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">This prospectus, any accompanying prospectus supplement and the documents incorporated by reference herein and therein contain &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and include this statement for purposes of complying with these safe harbor provisions.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">This document contains certain forward-looking statements with respect to the financial condition, results of operations and business, plans, objectives and strategies of Occidental. These statements may be made directly in this prospectus or may be incorporated by reference to other documents or in any accompanying prospectus supplement. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;predict,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;anticipate,&#8221; &#8220;plan,&#8221; &#8220;intend,&#8221; &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;aim,&#8221; &#8220;goal,&#8221; &#8220;target,&#8221; &#8220;objective,&#8221; &#8220;commit,&#8221; &#8220;advance,&#8221; &#8220;likely&#8221; or similar expressions that convey the prospective nature of events or outcomes. There are several factors which could cause actual plans and results to differ materially from those expressed or implied in forward-looking statements. Such factors include, but are not limited to:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">general economic conditions, including slowdowns, domestically or internationally;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our indebtedness and other payment obligations, including the need to generate sufficient cash flows to fund operations;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to successfully monetize select assets and repay or refinance debt and the impact of changes in our credit ratings;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the scope and duration of the COVID-19 pandemic and ongoing actions taken by governmental authorities and other third parties in response to the pandemic;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">assumptions about energy markets;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">global and local commodity and commodity-futures pricing fluctuations and volatility;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">supply and demand considerations for, and the prices of, our products and services;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">actions by the Organization of the Petroleum Exporting Countries (&#8220;OPEC&#8221;) and non-OPEC oil producing countries;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">results from operations and competitive conditions;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">future impairments of our proved and unproved oil and gas properties or equity investments, or write-downs of productive assets, causing charges to earnings; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">unexpected changes in costs;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">inflation and its impact on markets and economic activity;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">availability of capital resources, levels of capital expenditures and contractual obligations;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the regulatory approval environment, including our ability to timely obtain or maintain permits or other governmental approvals, including those necessary for drilling and/or development projects;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to successfully complete, or any material delay of, field developments, expansion projects, capital expenditures, efficiency projects, acquisitions or dispositions;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">risks associated with acquisitions, mergers and joint ventures, such as difficulties integrating businesses, uncertainty associated with financial projections, projected synergies, restructuring, increased costs and adverse tax consequences&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">uncertainties and liabilities associated with acquired and divested properties and businesses;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">uncertainties about the estimated quantities of oil, natural gas liquids and natural gas reserves;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">lower-than-expected production from development projects or acquisitions;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">3<br></div></div></div>
<!--End Page 22-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 23-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_204-fls_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to realize the anticipated benefits from prior or future streamlining actions to reduce fixed costs, simplify or improve processes and improve our competitiveness;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">exploration, drilling and other operational risks;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">disruptions to, capacity constraints in, or other limitations on the pipeline systems that deliver our oil and natural gas and other processing and transportation considerations;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">volatility in the securities, capital or credit markets;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">governmental actions, war (including the Russia-Ukraine war) and political conditions and events;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">legislative or regulatory changes, including changes relating to hydraulic fracturing or other oil and natural gas operations, retroactive royalty or production tax regimes, deep-water and onshore drilling and permitting regulations and environmental regulation (including regulations related to climate change);</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">environmental risks and liability under federal, regional, state, provincial, tribal, local and international environmental laws and regulations (including remedial actions);</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to recognize intended benefits from our business strategies and initiatives, such as our low carbon ventures business or announced greenhouse gas emissions reduction targets or net-zero goals;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">potential liability resulting from pending or future litigation;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">disruption or interruption of production or manufacturing or facility damage due to accidents, chemical releases, labor unrest, weather, power outages, natural disasters, cyber-attacks or insurgent activity;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the creditworthiness and performance of our counterparties, including financial institutions, operating partners and other parties;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">failure of risk management;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to retain and hire key personnel; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">supply, transportation and labor constraints;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reorganization or restructuring of our operations;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">changes in state, federal or international tax rates; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">actions by third parties that are beyond our control; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">other risk factors as detailed from time to time in our reports filed with the SEC, including our Annual Report on Form 10-K for the year ended December&#160;31, 2021, which is incorporated herein by reference, as well as any subsequent periodic or current reports filed with the SEC, including the risks and uncertainties set forth in, or incorporated by reference into, this prospectus in the section entitled &#8220;Risk Factors&#8221; beginning on page <a href="#tRF">5</a>. See &#8220;Where You Can Find More Information&#8221; beginning on page&#160;<a href="#tWYC">2</a>.</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments and other factors we believe appropriate. By their nature, forward-looking statements involve known and unknown risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. The factors described in the context of such forward-looking statements in this document could cause our plans, actual results, performance or achievements, industry results and developments to differ materially from those expressed in or implied by such forward-looking statements. Although we believe that the expectations reflected in such forward-looking statements are reasonable, we cannot assure you that such expectations will prove to have been correct and persons reading this document are therefore cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this prospectus or, in the case of a document incorporated by reference, as of the date of that document. We do not assume any obligation to update the information contained in this document (whether as a result of new information, future events or otherwise), except as required by applicable law.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">4<br></div></div></div>
<!--End Page 23-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 24-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_204-fls_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tAOC"><!--Anchor--></a>ABOUT OCCIDENTAL</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Our principal businesses consist of three reporting segments: oil and gas, chemical and midstream and marketing. The oil and gas segment explores for, develops and produces oil (which includes condensate), natural gas liquids (&#8220;NGL&#8221;) and natural gas. The chemical segment primarily manufactures and markets basic chemicals and vinyls. The midstream and marketing segment purchases, markets, gathers, processes, transports and stores oil (which&#160;includes condensate), NGL, natural gas, carbon dioxide and power. It also optimizes its transportation and storage capacity, and invests in entities that conduct similar activities, such as Western Midstream Partners, L.P.&#160;(&#8220;WES&#8221;).</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The midstream and marketing segment also includes our low carbon ventures (&#8220;OLCV&#8221;) businesses. OLCV seeks to leverage our legacy of carbon management expertise to develop carbon capture, utilization and storage projects, including the commercialization of direct air capture technology, and invests in other low-carbon technologies intended to reduce greenhouse gas emissions from our operations and strategically partner with other industries to help reduce their emissions.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Our principal executive offices are located at 5 Greenway Plaza, Suite 110, Houston, Texas 77046&#894; our telephone number is (713) 215-7000.</div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;"><a name="tRF"><!--Anchor--></a>RISK FACTORS</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Investing in our securities involves risks. Before you invest in our securities you should carefully consider the risk factors relating to an investment in our securities described in this prospectus, any applicable prospectus supplement and our Annual Report on Form 10-K for the year ended December&#160;31, 2021 and in any subsequent periodic or current reports filed with the SEC under the Exchange Act that include &#8220;Risk Factors&#8221; or that discuss risks to investing in our securities and that are incorporated herein by reference.</div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;"><a name="tUOP"><!--Anchor--></a>USE OF PROCEEDS</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Unless otherwise specified in an applicable prospectus supplement, we intend to use the net proceeds we receive from the sale of any securities offered under this prospectus for general corporate purposes, including, among other possible uses, repayment or refinancing of debt, acquisitions, working capital, capital expenditures and repurchases and redemptions of securities.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">5<br></div></div></div>
<!--End Page 24-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 25-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDOS"><!--Anchor--></a>DESCRIPTION OF SENIOR DEBT SECURITIES</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">General</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We may issue one or more series of senior debt securities pursuant to this prospectus. We will issue the senior debt securities under that certain indenture (the &#8220;Senior Indenture&#8221;), dated August&#160;8, 2019, between us and The Bank of New York Mellon Trust Company, N.A., as trustee (&#8220;Senior Indenture Trustee&#8221;). The Senior Indenture is included as an exhibit to the registration statement of which this prospectus is a part.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Below is a description of certain general terms of the senior debt securities. The description is not complete and is subject to and qualified in its entirety by reference to the Senior Indenture. The particular terms of a series of senior debt securities will be described in a prospectus supplement and, if applicable, a pricing supplement. Capitalized terms used but not defined in this summary have the meanings specified in the Senior Indenture.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The senior debt securities will rank equally with all of our unsecured and unsubordinated debt. The Senior Indenture is subject to the Trust Indenture Act of 1939, as amended (the &#8220;Trust Indenture Act&#8221;). The Senior Indenture does not limit the amount of senior debt securities which we may issue, nor does it limit us or our subsidiaries from issuing any other unsecured debt. Such other unsecured debt may have different terms than the senior debt securities. Our previously issued and outstanding senior debt may have different terms from the senior debt securities (including different restrictive covenants and event of default provisions). The terms of the senior debt securities issued under this prospectus will only be as described in the Senior Indenture, this prospectus and any prospectus supplement.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Each prospectus supplement, together with a pricing supplement, if applicable, will describe the terms relating to a series of senior debt securities, which may include:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the title&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any limit on the amount that may be issued (unless expressly provided in the applicable prospectus supplement or pricing supplement, a series of our senior debt securities may be re-opened from time to time for the issuance of additional senior debt securities of that series, subject to the terms and conditions set forth in or established pursuant to the Senior Indenture)&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the price at which that series of senior debt securities will be issued, which may be at a discount or a premium&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">whether or not that series of senior debt securities will be issued in global form and, if applicable, who the depositary will be&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the maturity date(s) or the method of determining the maturity date(s)&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the person to whom any interest will be payable on any senior debt security, if other than the person in whose name that security is registered at the close of business on the regular record date&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the interest rate(s), if any (which may be fixed or variable), or the method for determining the rate(s) and the date(s) interest will begin to accrue, the date(s) interest will be payable and the regular record date(s) for interest payment date(s)&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the place(s) where payments shall be payable, senior debt securities may be surrendered for registration of transfer, securities may be surrendered for exchange, and notices and demands to or upon us may be served&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the period(s) within which, and the price(s) at which, that series of senior debt securities may, pursuant to any optional or mandatory redemption provisions, be redeemed, in whole or in part, and other related terms and conditions&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any mandatory or optional sinking fund provisions or any provisions for remarketing that series of senior debt securities and other related terms and provisions&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the denominations in which that series of senior debt securities will be issued, if other than denominations of $2,000 and any integral multiple of $1,000 in excess thereof&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the currency or currencies, including composite currencies or currency units, in which that series of senior debt securities may be denominated or in which payment of the principal of and interest, if any, </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">6<br></div></div></div>
<!--End Page 25-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 26-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_bl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: left;">on that series of senior debt securities shall be payable, if other than the currency of the United States of America, and, if so, whether that series of senior debt securities may be satisfied and discharged other than as provided in Article Four of the Senior Indenture&#894;</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if the amounts of payments of principal of and any interest on, that series of senior debt securities are to be determined by reference to an index, formula or other method, or based on a coin or currency other than that in which that series of senior debt securities are stated to be payable, the manner in which such amounts shall be determined and the calculation agent, if any, with respect thereto&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if other than the principal amount thereof, the portion of the principal amount of that series of senior debt securities that will be payable upon declaration of acceleration of the maturity thereof pursuant to an event of default&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">whether we will pay additional amounts on any of the senior debt securities and coupons, if any, of the series to any non-United States holder in respect of any tax, assessment or governmental charge withheld or deducted, and under what circumstances and with what procedures we will pay such additional amounts&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if other than as defined in the Senior Indenture, the meaning of &#8220;Business Day&#8221; when used with respect to that series of senior debt securities&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if that series of senior debt securities may be issued or delivered (whether upon original issuance or upon exchange of a temporary security of such series or otherwise), or any installment of principal or interest is payable, only upon receipt of certain certificates or other documents or satisfaction of other conditions in addition to those specified in the Senior Indenture, the forms and terms of those certificates, documents or conditions&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any addition to, or modification or deletion of, any event of default, covenant or other term or provision specified in the Senior Indenture with respect to that series of senior debt securities&#894; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any other terms, which other terms may (subject, in the case of an existing outstanding series of senior debt securities, to the provisions of the Senior Indenture described below under &#8220;&#8212;Modification of Senior Indenture&#894; Waiver&#8221;) amend, supplement or replace any of the terms of the Senior Indenture insofar as it concerns the senior debt securities of that series.</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Each prospectus supplement or pricing supplement, as applicable, may describe certain United States federal income tax considerations applicable to the purchase, holding and disposition of the senior debt securities that the prospectus supplement or pricing supplement covers, as applicable.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Limitation on Liens</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The Senior Indenture provides that we will not, nor will we permit any Consolidated Subsidiary (as defined below) to, incur, create, assume, guarantee or otherwise become liable with respect to any Secured Debt (as defined below), unless the senior debt securities are secured equally and ratably with (or prior to) such Secured Debt. This covenant does not apply to:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Liens (as defined below) existing on the date of the Senior Indenture&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Liens existing on property of, or on any shares of Capital Stock or Indebtedness (each as defined below) of, any Business Entity (as defined below) at the time such Business Entity becomes a Consolidated Subsidiary or at the time such Business Entity is merged into or consolidated with us or any Consolidated Subsidiary or at the time of sale, lease or other disposition of the properties of such Business Entity (or a division of such Business Entity) to us or a Consolidated Subsidiary as an entirety or substantially as an entirety&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Liens in favor of us or a Consolidated Subsidiary&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(4)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Liens in favor of governmental bodies to secure progress, advance or other payments pursuant to any contract or provision of any statute&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(5)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Liens existing on property, shares of Capital Stock or Indebtedness at the time of acquisition thereof (including acquisition through merger or consolidation) or Liens to (i)&#160;secure the payment of all or any part of the purchase price of such property, shares or Indebtedness or the cost of construction, </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">7<br></div></div></div>
<!--End Page 26-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 27-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: left;">installation, expansion, renovation, improvement or development on or of such property or (ii)&#160;secure any Indebtedness incurred prior to, at the time of, or within two years after the latest of the acquisition, the completion of such construction, installation, expansion, renovation, improvement or development or the commencement of full operation of such property or within two years after the acquisition of such shares or Indebtedness for the purpose of financing all or any part of the purchase price or cost thereof&#894;</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(6)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Liens on any specific oil or gas property to secure Indebtedness incurred by us or any Consolidated Subsidiary to provide funds for all or any portion of the cost of exploration, production, gathering, processing, marketing, drilling or development of such property&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(7)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Liens on any Principal Domestic Property (as defined below) securing Indebtedness incurred under industrial development, pollution control or other revenue bonds issued or guaranteed by the United States of America or any State thereof or any department, agency, instrumentality or political subdivision thereof&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(8)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Liens on any Principal Domestic Property securing Indebtedness arising in connection with the sale of accounts receivable resulting from the sale of oil or gas at the wellhead&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(9)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">extensions, renewals or refundings of any Liens referred to in the foregoing clauses (1) through (8), subject to certain limitations&#894; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(10)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Liens on property or shares of Capital Stock of any WES Entity (as defined below).</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Notwithstanding the foregoing, we and one or more Consolidated Subsidiaries may incur, create, assume, guarantee or otherwise become liable with respect to any Secured Debt that would otherwise be subject to the foregoing restrictions if, after giving effect thereto, the aggregate amount of all Secured Debt would not exceed 15% of Consolidated Net Tangible Assets (as defined below).</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Consolidation, Merger or Sale</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The Senior Indenture does not permit us to consolidate with, merge into or convey, transfer or lease our properties and assets substantially as an entirety to any Business Entity unless the following conditions are met:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Business Entity formed by such consolidation or into which we are merged or the Business Entity that acquires by conveyance or transfer, or which leases, our properties and assets substantially as an entirety shall be a Business Entity organized and existing under the laws of the United States of America, any state thereof or the District of Columbia and shall expressly assume, by a supplemental indenture, all of our obligations under the Senior Indenture and the senior debt securities&#894; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">immediately after giving effect to such transaction, no event of default, or event that, after notice or lapse of time or both, would become an event of default, shall have occurred and be continuing.</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">If the conditions described above are satisfied with respect to the senior debt securities, we will not need to obtain the approval of the holders in order to engage in such a consolidation, merger, conveyance, transfer or lease. Also, these conditions will apply only if we wish to consolidate with or merge into, or convey, transfer or lease our properties and assets substantially as an entirety to, another entity. We will not need to satisfy these conditions if we enter into other types of transactions, including any transaction in which we acquire the stock or assets of another entity and any transaction that involves a change of control of Occidental but in which we do not consolidate with or merge into another entity, as well as any transaction in which we convey, transfer or lease our properties and assets other than substantially as an entirety to a Business Entity.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Reports</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The Senior Indenture provides that we will file with the Senior Indenture Trustee, within 15 days after we have filed the same with the United States Securities and Exchange Commission (the &#8220;Commission&#8221;), copies of the annual reports and of the information, documents and other reports (or copies of such portions of any of the foregoing as the Commission may from time to time by rules and regulations prescribe) which we may be required to file with the Commission pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934&#894; <font style="font-style: italic;">provided </font>that we will be deemed to have filed copies of any such annual reports, documents or other reports with the Senior Indenture Trustee to the extent that such annual reports, documents or other reports are filed with the Commission via EDGAR (or any successor electronic delivery procedure).</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">8<br></div></div></div>
<!--End Page 27-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 28-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Events of Default and Remedies Under the Senior Indenture</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The following are events of default under the Senior Indenture with respect to each series of senior debt securities:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">failure to pay any installment of interest upon any senior debt securities of such series when it becomes due and payable, and continuance of such failure to pay for a period of 30 days&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">failure to pay the principal of any senior debt securities of such series when due&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">failure to perform or breach of any other covenant or warranty contained in the senior debt securities or the Senior Indenture (other than a covenant or warranty specifically benefiting only another series of senior debt securities), and the continuance of such failure or breach for a period of 90 days after we receive notice of such failure or breach from the Senior Indenture Trustee or holders of at least 25% in principal amount of the outstanding senior debt securities of that series&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">certain events of bankruptcy, insolvency or reorganization relating to us&#894; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any other event of default specified in the prospectus supplement or pricing supplement, if any, relating to that series of senior debt securities.</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">If an event of default with respect to senior debt securities of any series occurs and is continuing, the Senior Indenture Trustee or the holders of at least 25% in principal amount of the outstanding senior debt securities of that series, by notice in writing to us (and to the Senior Indenture Trustee if notice is given by such holders), may declare the principal of (or if such senior debt securities are Original Issue Discount Securities, the portion of the principal amount specified in the applicable prospectus supplement or pricing supplement, if any), and accrued interest, if any, on the senior debt securities of such series to be due and payable immediately. At any time after such a declaration of acceleration has been made and before a judgment or decree for payment of the money due has been obtained, holders of a majority in principal amount of the outstanding senior debt securities of that series, by written notice to us and the Senior Indenture Trustee, may rescind and annul such declaration and its consequences if:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">we have paid or deposited with the Senior Indenture Trustee a sum sufficient to pay all overdue installments of interest on the senior debt securities of that series, the principal of any senior debt securities of that series which has become due otherwise than by such declaration of acceleration and interest thereon, to the extent payment of such interest is lawful, interest on overdue installments of interest, all sums paid or advanced by the Senior Indenture Trustee, the reasonable compensation, expenses, disbursements and advances of the Senior Indenture Trustee, its agents and counsel and any other amount due to the Senior Indenture Trustee under the Senior Indenture, and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">all events of default with respect to outstanding senior debt securities of that series, other than the non-payment of the principal of and interest on such senior debt securities which became due solely by such declaration of acceleration, have been cured or waived in accordance with the terms of the Senior Indenture.</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The holders of a majority in principal amount of the outstanding senior debt securities of any series may waive any past default with respect to that series and its consequences, except defaults regarding:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">payment of principal or interest&#894; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">covenants that cannot be modified or amended without the consent of each holder of an outstanding senior debt security affected thereby (as described under &#8220;-Modification of Senior Indenture&#894; Waiver&#8221; below).</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;">Any waiver shall cure such default and the corresponding event of default.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Subject to the terms of the Senior Indenture, the Senior Indenture Trustee will be under no obligation to exercise any of its rights or powers under the Senior Indenture at the request or direction of any of the holders of the applicable series of senior debt securities, unless the holders have offered the Senior Indenture Trustee reasonable security or indemnity against costs, expenses and liabilities to be incurred in compliance with such request. The </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">9<br></div></div></div>
<!--End Page 28-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 29-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">holders of a majority in principal amount of the outstanding senior debt securities of any series will have the right to direct the time, method and place of conducting any proceeding for any remedy available to the Senior Indenture Trustee, or exercising any trust or power conferred on the Senior Indenture Trustee, with respect to the senior debt securities of that series&#894; provided that:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the direction given to the Senior Indenture Trustee is not in conflict with any law or the Senior Indenture&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Senior Indenture Trustee may take any other action deemed proper by it which is not inconsistent with that direction&#894; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Senior Indenture Trustee has not determined that the action would be unjustly prejudicial to the holders not involved in the proceeding.</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">A holder of the senior debt securities of any series will have the right to institute a proceeding under the Senior Indenture or to appoint a receiver or trustee, or to seek other remedies only if:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the holder has given written notice to the Senior Indenture Trustee of a continuing event of default with respect to that series&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the holders of at least 25% in principal amount of the outstanding senior debt securities of that series have made written request, and have offered reasonable indemnity, to the Senior Indenture Trustee to institute the proceedings as trustee&#894; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Senior Indenture Trustee does not institute the proceeding, and does not receive from the holders of a majority in principal amount of the outstanding senior debt securities of that series other conflicting directions, within 60 days after the notice, request and offer of indemnity.</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The Senior Indenture provides that no holder or group of holders of senior debt securities will have any right to affect, disturb or prejudice the rights of other holders, obtain or seek priority or preference over another holder or enforce its rights under the Senior Indenture except as provided in the Senior Indenture for the equal and ratable benefit of all holders.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">These limitations on instituting proceedings do not apply to a suit instituted by a holder of senior debt securities to enforce the payment of the principal of or interest on the senior debt securities.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We will periodically deliver statements to the Senior Indenture Trustee regarding the existence or absence of defaults under the Senior Indenture.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Modification of Senior Indenture&#894; Waiver</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We and the Senior Indenture Trustee may amend or supplement the Senior Indenture without the consent of any holders to, among other things:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">evidence the succession of another Business Entity to us and the assumption by such successor of our covenants, agreements and obligations in the Senior Indenture and the senior debt securities&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">add to our covenants, agreements and obligations for the benefit of the holders of all senior debt securities or any series thereof, or to surrender any right or power the Senior Indenture confers upon us&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">add to or change any of the provisions of the Senior Indenture to permit the issuance of senior debt securities in uncertificated form;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">establish the form and terms of the senior debt securities of any series and (unless prohibited by the terms of the senior debt securities of any series pursuant to the Senior Indenture) to provide for the re-opening of a series of senior debt securities and for the issuance of additional senior debt securities of such series&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">evidence and provide for the acceptance of appointment under the Senior Indenture of a successor Senior Indenture Trustee with respect to the senior debt securities of one or more series&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">cure any ambiguity or correct or supplement any provision in the Senior Indenture that may be inconsistent with any other provision in the Senior Indenture or make other provisions with respect to matters or questions arising under the Senior Indenture&#894;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">10<br></div></div></div>
<!--End Page 29-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 30-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">add to, change or eliminate any provisions of the Senior Indenture (which addition, change or elimination may apply to one or more series of senior debt securities), <font style="font-style: italic;">provided</font>, that the addition, change or elimination neither (a) applies to any senior debt securities of any series created prior to the execution of the supplemental indenture that is entitled to the benefit of the provision nor (b) modifies the rights of holders of those senior debt securities with respect to those modified provisions&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">add to or change or eliminate any provision of the Senior Indenture as shall be necessary to comply with any amendments to the Trust Indenture Act or to otherwise maintain qualification of the Senior Indenture under the Trust Indenture Act or to comply with the rules of any applicable depositary&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">to conform the text of the Senior Indenture or the senior debt securities to any provision of the section &#8220;Description of Notes&#8221; (or equivalent title) in the offering memorandum or prospectus relating to the initial offering of such senior debt securities&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">secure the senior debt securities&#894; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">change anything else that does not adversely affect the interests of any holder of senior debt securities in any material respect.</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">In addition, under the Senior Indenture, the rights of holders of any series of senior debt securities may be changed by us and the Senior Indenture Trustee with the written consent of (i)&#160;the holders of not less than a majority in principal amount of all outstanding debt securities issued under the Senior Indenture voting as a single class or (ii)&#160;if fewer than all of the series of outstanding debt securities issued under the Senior Indenture are affected by such addition, change, elimination or modification, the holders of not less than a majority in principal amount of the outstanding securities of all series so affected by such supplemental indenture voting as a single class (including, for the avoidance of doubt, consents obtained in connection with a purchase of, or tender offer or exchange for, such debt securities), to execute a supplemental indenture to add provisions to, or change in any manner or eliminate any provisions of, the Senior Indenture with respect to such applicable series of debt securities or modify in any manner the rights of the holders of such applicable series of debt securities under the Senior Indenture.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">However, no change may be made without the consent of each holder of an outstanding senior debt security affected thereby if such change would, among other things:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">change the stated maturity of principal of, or any installment of principal or interest on, any such senior debt security&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reduce the principal amount of, or the rate of interest on, or any premium payable on, any such senior debt security&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">change the place where, or currency in which, any principal of or interest on any such senior debt security is payable&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">impair the right of the holders to institute suit for the enforcement of any payment of any such senior debt security on or after the stated maturity thereof (or, in the case of redemption, on or after the Redemption Date or, in the case of any senior debt security that is subject to repurchase or redemption by us at the option of the holders, on or after the date fixed for such repurchase or redemption)&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reduce the percentage in principal amount of outstanding senior debt securities of any series the holders of which are required to consent to any such change, or the consent of whose holders is required for any waiver of compliance with certain provisions of the Senior Indenture or certain defaults thereunder and their consequences with respect to the senior debt securities of such series provided for in the Senior Indenture&#894; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">modify any of the foregoing requirements or the provisions regarding waivers of any covenant or past default other than to increase the percentage of holders required for consent or waiver or add consent requirements for modification or waiver of other provisions.</div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Certain Definitions</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">&#8220;Business Entity&#8221; means a corporation, association, business trust, partnership, limited liability company or other business entity.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">11<br></div></div></div>
<!--End Page 30-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 31-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">&#8220;Capital Stock&#8221; means (a) in the case of a corporation, common stock, preferred stock and any other capital stock, (b) in the case of a partnership, partnership interests (whether general or limited), (c) in the case of a limited liability company, limited liability company interests, and (d) in the case of any other Business Entity, any other interest or participation that confers on a Person the right to receive a share of the profits and losses of, or distribution of assets of, such Business Entity, but excluding from all of the foregoing any debt securities convertible into Capital Stock, whether or not such debt securities include any right of participation with Capital Stock.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">&#8220;Consolidated Net Tangible Assets&#8221; means the total of the Net Tangible Assets of us and our Consolidated Subsidiaries included in our and our Consolidated Subsidiaries&#8217; financial statements prepared on a consolidated basis in accordance with United States generally accepted accounting principles, after eliminating all intercompany items.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">&#8220;Consolidated Subsidiary&#8221; means any subsidiary included in our and our subsidiaries&#8217; financial statements prepared on a consolidated basis in accordance with United States generally accepted accounting principles.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">&#8220;Current Liabilities&#8221; means all Indebtedness that may properly be classified as a current liability in accordance with United States generally accepted accounting principles.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">&#8220;Indebtedness&#8221; means, with respect to any Person, at any time, and in each case only to the extent such obligations are presented as liabilities on the face of the balance sheet of such Person in accordance with United States generally accepted accounting principles, (a) all obligations of such Person for borrowed money and all obligations of such Person evidenced by bonds, debentures, notes or similar instruments, (b) obligations under capital leases (the amount of such obligations being the capitalized amount of such leases, determined in accordance with United States generally accepted accounting principles as in effect on December&#160;31, 2016), (c)&#160;obligations of such Person to pay the deferred purchase price of property or services (other than trade accounts payable in the ordinary course of business), (d) all obligations, contingent or otherwise, of such Person as an account party in respect of letters of credit, letters of guaranty and bankers&#8217; acceptances, (e) guarantees by such Person of any Indebtedness of others of the type described in the foregoing clauses (a) through (d) and (f)&#160;all Indebtedness of others secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any Lien on any asset owned or acquired by such Person, whether or not the Indebtedness secured thereby has been assumed by such Person.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">&#8220;Lien&#8221; means and includes any mortgage, pledge, lien, security interest, conditional sale or other title retention agreement or other similar encumbrance to secure Indebtedness for borrowed money, but excluding (i)&#160;any security interest which a lessor may be deemed to have under a lease and (ii)&#160;any lien which may be deemed to exist under a Production Payment or under any subordination arrangement.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">&#8220;Net Tangible Assets&#8221; of any specified Person means the total of all assets properly appearing on a balance sheet of such Person prepared in accordance with United States generally accepted accounting principles, after deducting from such total, without duplication of deductions, (a) all Current Liabilities of such Person&#894; (b) that portion of the book amount of all such assets which would be treated as intangibles under United States generally accepted accounting principles, including, without limitation, all such items as goodwill, trademarks, trade names, brands, copyrights, patents, licenses and rights with respect to the foregoing and unamortized debt discount and expense&#894; and (c) the amount, if any, at which any Capital Stock of such Person appears on the asset side of such balance sheet.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">&#8220;Original Issue Discount Security&#8221; means any senior debt security which provides for an amount less than the principal amount thereof to be due and payable upon a declaration of acceleration of the Maturity thereof pursuant to the Senior Indenture.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">&#8220;Person&#8221; means any individual, corporation, partnership, limited liability company, joint venture, association, joint-stock company, trust, unincorporated organization or government or any agency or political subdivision thereof.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">&#8220;Principal Domestic Property&#8221; means any (1) developed oil or gas producing property or (2) processing or manufacturing plant, in each case which is owned or leased by us or any Consolidated Subsidiary and (i)&#160;which is located in the continental United States and (ii)&#160;the gross book value of which on the date of determination </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">12<br></div></div></div>
<!--End Page 31-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 32-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">exceeds 3% of Consolidated Net Tangible Assets&#894; <font style="font-style: italic;">provided</font>, <font style="font-style: italic;">however</font>, that any such property or plant declared by our Board of Directors by Board Resolution not to be of material importance to our and our Consolidated Subsidiaries&#8217; business, taken as a whole, will not be a Principal Domestic Property.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">&#8220;Production Payment&#8221; means any economic interest in oil, gas or mineral reserves which (1) entitles the holder thereof to a specified share of future production from such reserves, free of the costs and expenses of such production, and (2) terminates when a specified quantity of such share of future production from such reserves has been delivered or a specified sum has been realized from the sale of such share of future production from such reserves.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">&#8220;Redemption Date&#8221; when used with respect to any senior debt securities to be redeemed means the date fixed for such redemption by or pursuant to the Senior Indenture.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">&#8220;Secured Debt&#8221; means any Indebtedness of us or any Consolidated Subsidiary for borrowed money, secured by a Lien on any Principal Domestic Property or on any shares of Capital Stock of, or on any Indebtedness of, any Consolidated Subsidiary that owns any Principal Domestic Property.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">&#8220;subsidiary&#8221; means a Business Entity more than 50% of the outstanding Voting Stock of which is owned, directly or indirectly, by us or by one or more of our other subsidiaries, or by us and one or more of our other subsidiaries.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">&#8220;Voting Stock&#8221; means, with respect to any Business Entity, any class or series of Capital Stock of such Business Entity the holders of which are ordinarily, in the absence of contingencies, entitled to vote for the election of, or to appoint or to approve the appointment of, the directors, trustees or managing members of, or other persons holding similar positions with, such Business Entity.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">&#8220;WES Entities&#8221; means Western Midstream Partners, LP (formerly known as Western Gas Equity Partners, LP), Western Midstream Operating, LP (formerly known as Western Gas Partners, LP) and their respective Subsidiaries and general partners.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Form, Exchange and Transfer</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The senior debt securities of each series will be issued as registered securities. Unless otherwise specified in the applicable prospectus supplement or the pricing supplement, if any, senior debt securities will be issued in denominations of $2,000 and any integral multiple of $1,000 in excess thereof. Subject to the terms of the Senior Indenture and the limitations applicable to global securities described in the applicable prospectus supplement or the pricing supplement, if any, senior debt securities will be exchangeable for other senior debt securities of the same series, in any authorized denomination and of like tenor and aggregate principal amount.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Subject to the terms of the Senior Indenture and the limitations applicable to global senior debt securities set forth in the applicable prospectus supplement or pricing supplement, if any, senior debt securities issued may be presented for exchange or for registration of transfer (duly endorsed or with the form of transfer duly executed) at the office of the registrar or at the office of any transfer agent we designate for that purpose. Unless otherwise provided in the senior debt securities to be transferred or exchanged, no service charge will be made for any registration of transfer or exchange, but we may require payment of any taxes or other governmental charges. We have appointed the Senior Indenture Trustee as registrar. Any transfer agent (in addition to the registrar) initially designated by us for any senior debt securities will be named in the applicable prospectus supplement or pricing supplement. We may at any time designate additional transfer agents or rescind the designation of any transfer agent or approve a change in the office through which any transfer agent acts, except that we will be required to maintain a transfer agent in each place of payment for the senior debt securities of each series.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;">If the senior debt securities of any series are to be redeemed, we will not be required to:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">issue, register the transfer of, or exchange any senior debt securities of, that series during a period beginning at the opening of business 15 days before any selection of senior debt securities for redemption and ending on the day of mailing or sending of the relevant notice of redemption&#894; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">register the transfer of or exchange any senior debt securities so selected for redemption, in whole or in part, except the unredeemed portion of any senior debt security being redeemed in part.</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">13<br></div></div></div>
<!--End Page 32-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 33-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Global Senior Debt Securities</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The senior debt securities of each series may be issued in whole or in part in global form. A senior debt security in global form will be deposited with, or on behalf of, a depositary, which will be named in an applicable prospectus supplement or pricing supplement, if any. A global senior debt security shall be issued in registered form and in either temporary or definitive form. A global senior debt security may not be transferred, except as a whole, among the depositary for that senior debt security and its nominees and their respective successors. If any senior debt securities of a series are issuable as global senior debt securities, the applicable prospectus supplement or pricing supplement, if any, will describe any circumstances when beneficial owners of interests in that global senior debt security may exchange their interests for definitive senior debt securities of like series and tenor and principal amount in any authorized form and denomination.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;">Discharge</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Unless otherwise indicated in an applicable prospectus supplement or pricing supplement, if any, we may terminate at any time our obligations under the Senior Indenture with respect to any series of senior debt securities (other than certain limited obligations, such as the obligation to transfer and exchange senior debt securities of that series) by (1)(a) delivering all of the outstanding senior debt securities of that series to the Senior Indenture Trustee to be cancelled or (b) depositing with the Senior Indenture Trustee in trust funds or non-callable United States government or government-guaranteed obligations sufficient without reinvestment to pay all remaining principal and interest on the series of senior debt securities and (2) complying with certain other provisions of the Senior Indenture.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">If we elect to discharge our obligations by depositing cash or United States government or government guaranteed obligations as described above, under present law such discharge is likely to be treated for United States federal income tax purposes as a redemption of the senior debt securities of that series prior to maturity in exchange for the property deposited in trust. In that event, each holder would generally recognize, at the time of discharge, gain or loss for United States federal income tax purposes measured by the difference between (1) the sum of (a) the amount of any cash and (b) the fair market value of any property deposited in trust deemed received by such holder (unless attributable to accrued interest) and (2) such holder&#8217;s tax basis in the senior debt securities deemed surrendered. After the discharge, each such holder would likely be treated as if it held an undivided interest in the cash (or investments made therewith) and the property held in trust (or investments made with interest received therefrom). Each such holder would generally be subject to tax liability in respect of interest income and original issue discount, if applicable, thereon and would recognize any gain or loss upon any disposition, including redemption, of the assets held in trust. Although tax might be owed, the holder of a discharged senior debt security would not receive cash (except for current payments of interest on that senior debt security) until the maturity or earlier redemption (or, if applicable, repurchase by us at the option of the holder) of that senior debt security. United States federal income tax treatment of this nature could affect the purchase price that a holder would receive upon the sale of the senior debt securities. You are urged to consult with your tax advisor regarding the tax consequences of the discharge of our obligations.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;">Information Concerning the Senior Indenture Trustee</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The Senior Indenture Trustee, other than during the occurrence and continuance of an event of default under the Senior Indenture, undertakes to perform only those duties as are specifically set forth in the Senior Indenture and, upon an event of default under the Senior Indenture, must use the same degree of care as a prudent person would exercise or use in the conduct of his or her own affairs. Subject to this provision, the Senior Indenture Trustee is under no obligation to exercise any of the rights or powers given it by the Senior Indenture at the request or direction of any holder of senior debt securities unless the Senior Indenture Trustee is offered reasonable security or indemnity by that holder against the costs, expenses and liabilities that it might incur. The Senior Indenture Trustee is not required to spend or risk its own money or otherwise become financially liable while performing its duties unless it reasonably believes that it will be repaid or receive adequate indemnity.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The Bank of New York Mellon is a participating lender under our revolving credit agreement and provides commercial banking services to us and our affiliates. The Bank of New York Mellon Trust Company, N.A. is the Senior Indenture Trustee and will also act as Subordinated Indenture Trustee. However, if The Bank of New York Mellon Trust Company, N.A. acquires any conflicting interest when an event of default is pending, it must (with certain exceptions) eliminate the conflict or resign.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">14<br></div></div></div>
<!--End Page 33-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 34-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Payment and Payment Agents</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The person in whose name a senior debt security is registered will be treated as the owner of such security for the purpose of receiving payment of principal and, unless otherwise indicated in an applicable prospectus supplement or pricing supplement, if any, interest on such senior debt security and for all other purposes.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Unless otherwise indicated in the applicable prospectus supplement or pricing supplement, if any, payment of interest on any senior debt securities on any interest payment date will be made to the person in whose name those senior debt securities (or one or more predecessor securities) are registered at the close of business on the regular record date for the interest, except as otherwise provided by the procedures of the depositary. Unless otherwise indicated in the applicable prospectus supplement or pricing supplement, if any, principal and interest on the senior debt securities of a particular series will be payable at the office of the paying agents that we designate, except that payments of interest may, at our option, be made by wire transfer or check mailed to the address of the person entitled thereto.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We will be required to maintain a paying agent in each place of payment for the senior debt securities of a particular series. Unless otherwise indicated in the applicable prospectus supplement or pricing supplement, if any, the corporate trust office or agency of the Senior Indenture Trustee in The City of New York will be designated as the paying agent for payments with respect to senior debt securities.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">All moneys that we pay to a paying agent or the Senior Indenture Trustee for the payment of the principal or interest, if any, on any senior debt securities which remain unclaimed at the end of two years after that principal or interest has become due and payable will be repaid to us, and the holder of the security thereafter may look only to us for payment thereof.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Unless otherwise indicated in an applicable prospectus supplement or pricing supplement, if any, interest shall be computed, for fixed rate securities, on the basis of a 360-day year comprised of twelve 30-day months, and, for variable rate securities, on the basis of the actual number of days in the interest period divided by 360.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Governing Law</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The Senior Indenture and senior debt securities are governed by and construed in accordance with the law of the State of New York (without regard to conflicts of laws principles thereof).</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">15<br></div></div></div>
<!--End Page 34-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 35-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDOD"><!--Anchor--></a>DESCRIPTION OF SUBORDINATED DEBT SECURITIES</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">General</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We may issue one or more series of subordinated debt securities pursuant to this prospectus. We may issue the subordinated debt securities under an indenture (the &#8220;Subordinated Indenture&#8221;), to be entered into in the future among us, the subsidiary guarantors of such debt securities, if any, and The Bank of New York Mellon Trust Company, N.A., or another entity, as trustee (&#8220;Subordinated Indenture Trustee&#8221;). The form of Subordinated Indenture is included as an exhibit to the registration statement of which this prospectus is a part.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Below is a description of certain general terms of the subordinated debt securities. The description is not complete and is subject to and qualified in its entirety by reference to the Subordinated Indenture. The particular terms of a series of subordinated debt securities will be described in a prospectus supplement and, if applicable, a pricing supplement. Capitalized terms used but not defined in this summary have the meanings specified in the Subordinated Indenture.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The subordinated debt securities will be unsecured and will be subordinated and junior in priority of payment to our Senior Indebtedness (as defined below). The Subordinated Indenture is subject to the Trust Indenture Act. The Subordinated Indenture does not limit the amount of Senior Indebtedness or subordinated debt securities which we may issue, nor does it limit us or our subsidiaries from issuing any debt.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Each prospectus supplement, together with a pricing supplement, if applicable, will describe the terms relating to a series of subordinated debt securities, which may include:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the title;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any limit on the amount that may be issued (unless expressly provided in the applicable prospectus supplement or pricing supplement, a series of our subordinated debt securities may be re-opened from time to time for the issuance of additional subordinated debt securities of that series, subject to any terms and conditions set forth in or established pursuant to the Subordinated Indenture);</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the price at which that series of subordinated debt securities will be issued, which may be at a discount or a premium;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">whether or not that series of subordinated debt securities will be issued in global form, and, if applicable, who the depositary will be;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the maturity date(s) or the method of determining the maturity date(s);</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the person to whom any interest will be payable on any subordinated debt security, if other than the person in whose name that security is registered at the close of business on the regular record date;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the interest rate(s), if any (which may be fixed or variable), or the method for determining the rate(s) and the date(s) interest will begin to accrue, the date(s) interest will be payable and the regular record date(s) for interest payment date(s);</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the place(s) where payments shall be payable, subordinated debt securities may be surrendered for registration of transfer, securities may be surrendered for exchange, and notices and demands to or upon us may be served;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the period(s) within which, and the price(s) at which, that series of subordinated debt securities may, pursuant to any optional or mandatory redemption provisions, be redeemed, in whole or in part, and other related terms and conditions;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any mandatory or optional sinking fund provisions or any provisions for remarketing that series of subordinated debt securities and other related terms and provisions;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the denominations in which that series of subordinated debt securities will be issued, if other than denominations of $2,000 and any integral multiple of $1,000 in excess thereof;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the currency or currencies, including composite currencies or currency units, in which that series of subordinated debt securities may be denominated or in which payment of the principal of and interest, </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">16<br></div></div></div>
<!--End Page 35-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 36-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg12"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_bl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: left;">if any, on that series of subordinated debt securities shall be payable, if other than the currency of the United States of America, and, if so, whether that series of subordinated debt securities may be satisfied and discharged other than as provided in Article Four of the Subordinated Indenture;</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if the amounts of payments of principal of and any interest on that series of subordinated debt securities are to be determined by reference to an index, formula or other method, or based on a coin or currency other than that in which that series of subordinated debt securities are stated to be payable, the manner in which such amounts shall be determined and the calculation agent, if any, with respect thereto;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if other than the principal amount thereof, the portion of the principal amount of that series of subordinated debt securities that will be payable upon declaration of acceleration of the maturity thereof pursuant to an event of default;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">whether we will pay additional amounts on any of the subordinated debt securities and coupons, if any, of the series to any non-United States holder in respect of any tax, assessment or governmental charge withheld or deducted, and under what circumstances and with what procedures we will pay such additional amounts;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if other than as defined in the Subordinated Indenture, the meaning of &#8220;Business Day&#8221; when used with respect to that series of subordinated debt securities;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if that series of subordinated debt securities may be issued or delivered (whether upon original issuance or upon exchange of a temporary security of such series or otherwise), or any installment of principal or interest is payable, only upon receipt of certain certificates or other documents or satisfaction of other conditions in addition to those specified in the Subordinated Indenture, the forms and terms of those certificates, documents or conditions;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the right, if any, to extend the interest payment periods and the duration of the extensions;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the terms pursuant to which any series of subordinated debt securities will be subordinate to any of our debt, if different from those described under &#8220;&#8212;Subordination&#8221; below;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any addition to, or modification or deletion of, any event of default, covenant or other term or provision specified in the Subordinated Indenture with respect to that series of subordinated debt securities; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any other terms, which other terms may, subject, in the case of an existing outstanding series of subordinated debt securities, to the provisions of the Subordinated Indenture described below under &#8220;&#8212;Modification of Subordinated Indenture; Waiver,&#8221; amend, supplement or replace any of the terms of the Subordinated Indenture insofar as it concerns the subordinated debt securities of that series.</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Each prospectus supplement or pricing supplement, as applicable, may describe certain United States federal income tax considerations applicable to the purchase, holding and disposition of the subordinated debt securities that the prospectus supplement or pricing supplement covers, as applicable.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Subordination</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The payment of the principal of, and premium, if any, and interest on, and any other amounts payable with respect to the subordinated debt securities will be subordinated, to the extent and in the manner set forth in the Subordinated Indenture, in right of payment to the prior payment in full of all Senior Indebtedness, whether such Subordinated Indebtedness is outstanding at the time such subordinated debt securities are issued or incurred thereafter. The Subordinated Indenture does not limit or prohibit us from incurring Senior Indebtedness. Holders of subordinated debt securities should also recognize that contractual provisions in the Subordinated Indenture may prohibit us from making payments on the subordinated debt securities under specified circumstances.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">&#8220;Senior Indebtedness&#8221; means the principal of, premium, if any, and interest on (including interest accruing after the filing of a petition initiating any proceeding pursuant to any Federal bankruptcy law or any other applicable Federal or State law, but only to the extent allowed or permitted to the holder of such Indebtedness of the Company against the bankruptcy or any other insolvency estate of the Company in such proceeding) and other amounts due on or in connection with any Indebtedness of the Company incurred, assumed or guaranteed by the Company, whether outstanding on the date of the Subordinated Indenture or thereafter incurred, assumed or </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">17<br></div></div></div>
<!--End Page 36-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 37-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg13"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">guaranteed and all renewals, extensions and refundings of any such Indebtedness of the Company; <font style="font-style: italic;">provided, however,</font> that the following will not constitute Senior Indebtedness:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any of our Indebtedness as to which, in the instrument creating the same or evidencing the same or pursuant to which the same is outstanding, it is expressly provided that such Indebtedness shall be subordinated to or <font style="font-style: italic;">pari passu</font> with the subordinated debt securities;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(b)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Indebtedness of the Company in respect of the subordinated debt securities;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(c)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any of our Indebtedness constituting trade accounts payable arising in the ordinary course of business;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(d)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any of our Indebtedness initially issued to any Capital Trust (as defined below) in connection with an issuance by such Capital Trust of preferred securities or other securities similar to preferred securities; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(e)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any of our Indebtedness owed to any of our subsidiaries.</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">&#8220;Indebtedness,&#8221; as applied to a person, means, as of the date on which Indebtedness is to be determined and without duplication (i)&#160;all obligations represented by notes, bonds, debentures or similar evidences of indebtedness; (ii)&#160;all indebtedness for borrowed money or for the deferred purchase price of property or services other than, in the case of any such deferred purchase price, on normal trade terms; (iii)&#160;all rental obligations as lessee under leases which shall have been or should be, in accordance with generally accepted accounting principles, recorded as capital leases; and (iv)&#160;all Indebtedness of others for the payment of which such person is responsible or liable as obligor or guarantor.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">&#8220;Capital Trust&#8221; means any Delaware business trust, or any other similar trust, or any partnership or other entity affiliated with us created for the purpose of issuing securities in connection with the issuance of subordinated debt securities under the Subordinated Indenture.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Even if the subordination provisions prevent us from making any payment when due on the subordinated debt securities of any series, we will be in default on our obligations under that series if we do not make the payment when due (subject to any applicable grace period). This means that the Subordinated Trustee and the holders of subordinated debt securities of that series can take action against us, but they will not receive any money until the claims of the holders of Senior Indebtedness have been fully satisfied.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;">Payment Over of Proceeds Upon Dissolution, Etc.<font style="font-style: normal;"> The Subordinated Indenture provides that, upon any distribution of our assets in the event of:</font></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any insolvency or bankruptcy case or proceeding, or any receivership, liquidation, reorganization or other similar case or proceeding in connection therewith, relative to us or our creditors, as such, or to our assets, or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our liquidation, dissolution or other winding up, whether voluntary or involuntary and whether or not involving insolvency or bankruptcy, or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any assignment for the benefit of our creditors or any other marshalling of our assets and liabilities,</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">then and in such event:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the holders of Senior Indebtedness shall be entitled to receive payment in full of all amounts due or to become due on or in respect of all Senior Indebtedness, or provision shall be made for such payment in cash, before the holders of the subordinated debt securities of any series are entitled to receive any payment on account of the principal amount, interest or any such other amounts as may be payable under the Subordinated Indenture, if any, in respect of the subordinated debt securities of such series; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(b)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any payment or distribution of our assets of any kind or character, whether in cash, property or securities, by set-off or otherwise, to which the holders of the subordinated debt securities or the Subordinated Indenture Trustee would be entitled but for the subordination provisions of the Subordinated Indenture, including any such payment or distribution which may be payable or deliverable by reason of the payment of any other Indebtedness of the Company being subordinated to the payment of the securities of such series, shall be paid by the liquidating trustee or agent or other person making such payment or distribution, whether a trustee in bankruptcy, a receiver or liquidating </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">18<br></div></div></div>
<!--End Page 37-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 38-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg14"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: left;">trustee or otherwise, directly to the holders of Senior Indebtedness or their representative or representatives or to the trustee or trustees under any indenture under which any instruments evidencing any of such Senior Indebtedness may have been issued, ratably according to the aggregate amounts remaining unpaid on account of the principal of, and premium, if any, and interest on the Senior Indebtedness held or represented by each, to the extent necessary to make payment in full of all Senior Indebtedness remaining unpaid, after giving effect to any concurrent payment or distribution to the holders of such Senior Indebtedness.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">In the event that, notwithstanding the provisions described in the preceding paragraph, the Subordinated Indenture Trustee or the holder of any subordinated debt security of any series receives any payment or distribution of our assets of any kind or character, whether in cash, property or securities, including any such payment or distribution which may be payable or deliverable by reason of the payment of any other Indebtedness of the Company being subordinated to the payment of the securities of such series, before all Senior Indebtedness is paid in full or payment thereof provided for, and if such fact has been made known to the Subordinated Indenture Trustee as provided in the Subordinated Indenture, or, as the case may be, such holder of subordinated debt securities, then and in such event such payment or distribution shall be paid over or delivered forthwith to the trustee in bankruptcy, receiver, liquidating trustee, custodian, assignee, agent or other person making payment or distribution of our assets for application to the payment of all Senior Indebtedness remaining unpaid, to the extent necessary to pay all Senior Indebtedness in full, after giving effect to any concurrent payment or distribution to or for the holders of Senior Indebtedness.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">By reason of such subordination, in the event of any distribution of our assets in connection with any insolvency, bankruptcy, receivership, liquidation, reorganization or other similar proceedings relating to us, or our liquidation, dissolution or winding up, or any assignment for the benefit of our creditors or other marshalling of our assets and liabilities:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">holders of Senior Indebtedness will be entitled to be paid in full before payments may be made on the subordinated debt securities and the holders of subordinated debt securities will be required to pay over their share of such distribution, to the extent made in respect of such subordinated debt securities, to the holders of Senior Indebtedness until such Senior Indebtedness is paid in full; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our creditors who are neither holders of subordinated debt securities nor holders of Senior Indebtedness may recover more, ratably, than the holders of the subordinated debt securities.</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Furthermore, such subordination may result in a reduction or elimination of payments to the holders of subordinated debt securities.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Our consolidation with, or our merger into, another corporation or our liquidation or dissolution following the conveyance or transfer of our properties and assets substantially as an entirety to another person upon the terms and conditions described below under &#8220;&#8212;Consolidation, Merger or Sale,&#8221; will not be deemed a dissolution, winding up, liquidation, reorganization, assignment for the benefit of creditors or marshalling of our assets and liabilities for the purposes of the subordination provisions of the Subordinated Indenture if the person formed by such consolidation or into which we are merged or the person which acquires by conveyance or transfer our properties and assets substantially as an entirety, as the case may be, will, as a part of such consolidation, merger, conveyance or transfer, comply with the conditions described under &#8220;&#8212;Consolidation, Merger or Sale.&#8221;</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;">Prior Payment to Senior Indebtedness upon Acceleration of Subordinated Debt Securities.<font style="font-style: normal;"> In the event that any subordinated debt securities of any series are declared due and payable before their stated maturity, the holders of Senior Indebtedness will be entitled to receive payment in full of all amounts due or to become due on or in respect of all Senior Indebtedness or provision will be made for such payment in cash, before the holders of the subordinated debt securities of such series are entitled to receive any payment from us on account of the principal, premium, interest or any other amounts that may be payable in respect of the subordinated debt securities of such series or on account of the purchase or other acquisition of subordinated debt securities of such series. In the event that we make any payment to the Subordinated Indenture Trustee or the holder of any subordinated debt securities of any series that is prohibited by the provisions described in the immediately preceding sentence, then such payment generally must be paid over and delivered to us by the person holding such payment for the benefit of the holders of Senior Indebtedness. The provisions described in this paragraph do not apply to any payment with respect to which the provisions described above under the caption &#8220;&#8212;Payment Over of Proceeds Upon Dissolution, Etc.&#8221; would be applicable.</font></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">19<br></div></div></div>
<!--End Page 38-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 39-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg15"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Default in Senior Indebtedness.<font style="font-style: normal;"> In the event and during the continuation of any default by us in the payment of principal, premium, if any, interest or any other payment due on any of our Senior Indebtedness beyond any applicable grace period with respect thereto, or in the event that the maturity of any of our Senior Indebtedness has been accelerated because of a default, then, in any such case, no payment will be made by us with respect to the principal, premium, or interest or any other amounts that may be payable on the subordinated debt securities until such default is cured or waived or ceases to exist or any such acceleration or demand for payment has been rescinded.</font></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;">Other.<font style="font-style: normal;"> We are required to give prompt written notice to the Subordinated Indenture Trustee of any fact known to us which would prohibit the making of any payment in respect of the subordinated debt securities of any series.</font></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">If this prospectus is being delivered in connection with the offering of subordinated debt securities, the accompanying prospectus supplement or pricing supplement or information incorporated by reference herein will set forth the approximate amount of Senior Indebtedness outstanding as of a recent date.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Consolidation, Merger or Sale</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The Subordinated Indenture generally permits us to consolidate with, merge into or convey, transfer or lease our properties and assets substantially as an entirety, to any person, so long as, immediately after giving effect to such transaction, no event of default under the Subordinated Indenture or event which, after notice or lapse of time or both, would become an event of default shall have occurred and be continuing. However, any successor or acquiror of such assets must assume all of our obligations under the Subordinated Indenture and the subordinated debt securities and be organized and existing under the laws of the United States of America, any state thereof or the District of Columbia.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Events of Default Under the Subordinated Indenture</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The following are events of default under the Subordinated Indenture with respect to each series of subordinated debt securities:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">default in the payment of any installment of interest upon any subordinated debt security of such series when it becomes due and payable, and continuance of such default for a period of 30 days; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">default in the payment of the principal of any subordinated debt security of such series when due; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">default in the performance, or breach, of any covenant or warranty of the Company in the Subordinated Indenture (other than a covenant or warranty a default in whose performance or whose breach is specifically dealt with or which has been expressly included in the Subordinated Indenture solely for the benefit of a series of subordinated debt securities other than such series), and continuance of such default or breach for a period of 90 days after there has been given, by registered or certified mail, to the Company by the Trustee or to the Company and the Trustee by the Holders of at least 25% in principal amount of the outstanding subordinated debt securities of such series a written notice specifying such default or breach and requiring it to be remedied and stating that such notice is a &#8220;Notice of Default&#8221; hereunder; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the entry of a decree or order by a court having jurisdiction in the premises adjudging the Company a bankrupt or insolvent, or approving as properly filed a petition seeking reorganization, arrangement, adjustment or composition of or in respect of the Company under Federal bankruptcy law or any other applicable Federal or State law, or appointing a receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Company or of any substantial part of its property, or ordering the winding up or liquidation of its affairs, and the continuance of any such decree or order unstayed and in effect for a period of 60 consecutive days; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the institution by the Company of proceedings to be adjudicated a bankrupt or insolvent, or the consent by it to the institution of bankruptcy or insolvency proceedings against it, or the filing by it of a petition or answer or consent seeking reorganization or relief under Federal bankruptcy law or any other applicable Federal or state law, or the consent by it to the filing of such petition or to the appointment of a receiver, liquidator, assignee, trustee, sequestrator or similar official of the Company or of any substantial part of its property, or the making by it of an assignment for the benefit of creditors, or the admission by it in writing of its inability to pay its debts generally as they become due, or the taking of corporate action by the Company in furtherance of any such action; or</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">20<br></div></div></div>
<!--End Page 39-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 40-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg16"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any other event designated as an event of default in the prospectus supplement or pricing supplement, if any, with respect to subordinated debt securities of that series.</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">If an event of default with respect to subordinated debt securities of any series occurs and is continuing, the Subordinated Indenture Trustee or the holders of not less than 25% in principal amount of the outstanding subordinated debt securities of that series, by notice in writing to us (and to the Subordinated Indenture Trustee if notice is given by such holders), may declare the principal of (or if such subordinated debt securities are discount securities, the portion of the principal amount specified in the applicable prospectus supplement or pricing supplement, if any), and accrued interest, if any, due and payable immediately. At any time after such a declaration of acceleration has been made and before a judgment or decree for payment of the money due has been obtained holders of a majority in principal amount of the outstanding subordinated debt securities of that series, by written notice to us and the Subordinated Indenture Trustee, may rescind and annul such declaration and its consequences if:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">we have paid or deposited with the Subordinated Indenture Trustee a sum sufficient to pay all overdue installments of interest on the subordinated debt securities of that series, the principal of any subordinated debt securities of that series which have become due otherwise than by such declaration of acceleration and interest thereon, to the extent payment of such interest is lawful, interest on overdue installments of interest, all sums paid or advanced by the Subordinated Indenture Trustee, the reasonable compensation, expenses, disbursements and advances of the Subordinated Indenture Trustee, its agents and counsel and any other amount due to the Subordinated Indenture Trustee under the Subordinated Indenture, and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">all events of default with respect to outstanding subordinated debt securities of that series, other than the non-payment of the principal of and interest on such subordinated debt securities which became due solely by such declaration of acceleration, have been cured or waived in accordance with the terms of the Subordinated Indenture.</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The holders of a majority in principal amount of the outstanding subordinated debt securities of any series may waive any past default with respect to that series and its consequences, except defaults regarding:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">payment of principal or interest; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">covenants that cannot be modified or amended without the consent of the holder of each outstanding subordinated debt security of such series affected (as described under &#8220;&#8212;Modification of Subordinated Indenture; Waiver&#8221; below).</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;">Any waiver shall cure such default and the corresponding event of default.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Subject to the terms of the Subordinated Indenture, the Subordinated Indenture Trustee will be under no obligation to exercise any of its rights or powers under the Subordinated Indenture at the request or direction of any of the holders of the applicable series of subordinated debt securities, unless the holders have offered the Subordinated Indenture Trustee reasonable security or indemnity against costs, expenses and liabilities to be incurred in compliance with such request. The holders of a majority in principal amount of the outstanding subordinated debt securities of any series will have the right to direct the time, method and place of conducting any proceeding for any remedy available to the Subordinated Indenture Trustee, or exercising any trust or power conferred on the Subordinated Indenture Trustee, with respect to the subordinated debt securities of that series, <font style="font-style: italic;">provided </font>that:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the direction given to the Subordinated Indenture Trustee is not in conflict with any law or the Subordinated Indenture;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Subordinated Indenture Trustee may take any other action deemed proper by it which is not inconsistent with that direction; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Subordinated Indenture Trustee has not determined that the action would be unjustly prejudicial to the holders not involved in the proceeding.</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">21<br></div></div></div>
<!--End Page 40-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 41-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg17"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">A holder of the subordinated debt securities of any series will have the right to institute a proceeding under the Subordinated Indenture or to appoint a receiver or trustee, or to seek other remedies only if:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the holder has given written notice to the Subordinated Indenture Trustee of a continuing event of default with respect to the subordinated debt securities of that series;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the holders of not less than 25% in principal amount of the outstanding subordinated debt securities of that series have made written request, and have offered reasonable indemnity, to the Subordinated Indenture Trustee to institute the proceedings as trustee; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Subordinated Indenture Trustee does not institute the proceeding, and does not receive from the holders of a majority in principal amount of the outstanding subordinated debt securities of that series other conflicting directions, within 60 days after the notice, request and offer of indemnity.</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The Subordinated Indenture provides that no holder or group of holders of subordinated debt securities will have any right to affect, disturb or prejudice the rights of other holders, obtain or seek priority or preference over another holder or enforce its rights under the Subordinated Indenture except as provided in the Subordinated Indenture for the equal and ratable benefit of all holders.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">These limitations on instituting proceedings do not apply to a suit instituted by a holder of subordinated debt securities to enforce the payment of the principal of or interest on the subordinated debt securities.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We will periodically file statements with the Subordinated Indenture Trustee regarding our compliance with the conditions and covenants in the Subordinated Indenture.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Modification of Subordinated Indenture; Waiver</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We and the Subordinated Indenture Trustee may amend or supplement the Subordinated Indenture without the consent of any holders to, among other things:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">evidence the succession of another person and the assumption by such person of our covenants in the Subordinated Indenture and subordinated debt securities;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">add to our covenants, agreements and obligations for the benefit of the holders of all subordinated debt securities or any series thereof, or to surrender any right or power the Subordinated Indenture confers upon us;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">establish the form and terms of the subordinated debt securities of any series and (unless prohibited by the terms of the subordinated debt securities of any series pursuant to the Subordinated Indenture) to provide for the re-opening of a series of subordinated debt securities and for the issuance of additional subordinated debt securities of such series;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">evidence and provide for the acceptance of appointment under the Subordinated Indenture of a successor Subordinated Indenture Trustee with respect to the subordinated debt securities of one or more series;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">cure any ambiguity, to correct or supplement any provision in the Subordinated Indenture which may be inconsistent with any other provision in the Subordinated Indenture or make other provisions with respect to matters or questions arising under the Subordinated Indenture;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">add to, change or eliminate any provisions of the Subordinated Indenture (which addition, change or elimination may apply to one or more series of subordinated debt securities), <font style="font-style: italic;">provided</font> that the addition, change or elimination neither (a) applies to any subordinated debt security of any series created prior to the execution of the supplemental indenture that is entitled to the benefit of the provision nor (b)&#160;modifies the rights of holders of those subordinated debt securities with respect to those modified provisions;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">add to or change or eliminate any provision of the Subordinated Indenture as shall be necessary to comply with any amendments to the Trust Indenture Act or to otherwise maintain qualification of the Subordinated Indenture under the Trust Indenture Act or to comply with the rules of any applicable depositary&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">secure the subordinated debt securities; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">change anything else that does not adversely affect the interests of any holder of subordinated debt securities.</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">22<br></div></div></div>
<!--End Page 41-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 42-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg18"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">In addition, under the Subordinated Indenture, the rights of holders of a series of subordinated debt securities may be changed by us and the Subordinated Indenture Trustee with the written consent of the holders of at least a majority in principal amount of the outstanding subordinated debt securities of each series that is affected. However, no change may be made without the consent of the holder of each outstanding subordinated debt security affected if such change would, among other things:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">change the stated maturity of principal of, or any installment of principal or interest on, any such subordinated debt security;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reduce the principal amount of a discount security payable upon declaration of acceleration;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reduce the principal amount of, or the rate of interest on, or reduce any premium payable on, any of the subordinated debt securities;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">change the place where, or currency in which, any principal of or interest on any such subordinated debt security is payable;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">impair the right to institute suit for the enforcement of any payment on or with respect to any of the subordinated debt securities;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">change the terms of the subordination of the subordinated debt securities in a manner adverse to the holders of any series of outstanding subordinated debt securities;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reduce the percentage in principal amount of outstanding subordinated debt securities of any series, the holders of which are required to consent to any such change, or the consent of whose holders is required for any waiver (of compliance with certain provisions of the Subordinated Indenture or certain defaults thereunder and their consequences) with respect to the subordinated debt securities of such series provided for in the Subordinated Indenture; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">modify any of the foregoing requirements or the provisions regarding waivers of any covenant or past default other than to increase the percentage of holders required for consent or waiver or add consent requirements for modification of waiver or other provisions.</div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Form, Exchange and Transfer</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The senior debt securities of each series will be issued as registered securities. Unless otherwise specified in the applicable prospectus supplement or the pricing supplement, if any, subordinated debt securities will be issued in denominations of $2,000 and any integral multiple of $1,000 in excess thereof. Subject to the terms of the Subordinated Indenture and the limitations applicable to global securities described in the applicable prospectus supplement or the pricing supplement, if any, subordinated debt securities will be exchangeable for other subordinated debt securities of the same series, in any authorized denomination and of like tenor and aggregate principal amount.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Subject to the terms of the Subordinated Indenture and the limitations applicable to global subordinated debt securities set forth in the applicable prospectus supplement or pricing supplement, if any, subordinated debt securities may be presented for exchange or for registration of transfer (duly endorsed or with the form of transfer duly executed) at the office of the registrar or at the office of any transfer agent we designate for that purpose. Unless otherwise provided in the subordinated debt securities to be transferred or exchanged, no service charge will be made for any registration of transfer or exchange, but we may require payment of any taxes or other governmental charges. We have appointed the Subordinated Indenture Trustee as registrar. Any transfer agent (in addition to the registrar) initially designated by us for any subordinated debt securities will be named in the applicable prospectus supplement or pricing supplement. We may at any time designate additional transfer agents or rescind the designation of any transfer agent or approve a change in the office through which any transfer agent acts, except that we will be required to maintain a transfer agent in each place of payment for the subordinated debt securities of each series.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">23<br></div></div></div>
<!--End Page 42-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 43-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg19"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">If the subordinated debt securities of any series are to be redeemed, we will not be required to:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">issue, register the transfer of, or exchange any subordinated debt securities of, that series during a period beginning at the opening of business 15 days before any selection of subordinated debt securities for redemption and ending on the day of mailing or sending of the relevant notice of redemption; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">register the transfer of or exchange any subordinated debt securities so selected for redemption, in whole or in part, except the unredeemed portion of any subordinated debt security being redeemed in part.</div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">Global Subordinated Debt Securities</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The subordinated debt securities of each series may be issued in whole or in part in global form. A subordinated debt security in global form will be deposited with, or on behalf of, a depositary, which will be named in an applicable prospectus supplement or pricing supplement, if any. A global subordinated debt security shall be issued in registered form in either temporary or definitive form. A global subordinated debt security may not be transferred, except as a whole among the depositary for that subordinated debt security and its nominees and their respective successors. If any subordinated debt securities of a series are issuable as global subordinated debt securities, the applicable prospectus supplement or pricing supplement, if any, will describe any circumstances when beneficial owners of interests in that global subordinated debt security may exchange their interests for definitive subordinated debt securities of like series and tenor and principal amount in any authorized form and denomination.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">Discharge</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Unless otherwise indicated in an applicable prospectus supplement or pricing supplement, if any, we may terminate at any time our obligations under the Subordinated Indenture with respect to any series of subordinated debt securities (other than certain limited obligations, such as the obligation to transfer and exchange subordinated debt securities of that series) by (1)(a) delivering all of the outstanding subordinated debt securities of that series to the Subordinated Indenture Trustee to be cancelled or (b) depositing with the Subordinated Indenture Trustee in trust funds or non-callable United States government or government-guaranteed obligations sufficient without reinvestment to pay all remaining principal and interest on the series of subordinated debt securities and (2) complying with certain other provisions of the Subordinated Indenture.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">If we elect to discharge our obligations by depositing cash or United States government or government guaranteed obligations as described above, under present law such discharge is likely to be treated for United States federal income tax purposes as a redemption of the subordinated debt securities of that series prior to maturity in exchange for the property deposited in trust. In that event, each holder would generally recognize, at the time of discharge, gain or loss for United States federal income tax purposes measured by the difference between (1) the sum of (a) the amount of any cash and (b) the fair market value of any property deposited in trust deemed received by such holder (unless attributable to accrued interest) and (2) such holder&#8217;s tax basis in the subordinated debt securities deemed surrendered. After the discharge, each such holder would likely be treated as if it held an undivided interest in the cash (or investments made therewith) and the property held in trust (or investments made with interest received therefrom). Each such holder would generally be subject to tax liability in respect of interest income and original issue discount, if applicable, thereon and would recognize any gain or loss upon any disposition, including redemption, of the assets held in trust. Although tax might be owed, the holder of a discharged subordinated debt security would not receive cash (except for current payments of interest on that subordinated debt security) until the maturity or earlier redemption (or, if applicable, repurchase by us at the option of the holder) of that subordinated debt security. United States federal income tax treatment of this nature could affect the purchase price that a holder would receive upon the sale of the subordinated debt securities. You are urged to consult with your tax advisor regarding the tax consequences of the discharge of our obligations.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Information Concerning the Subordinated Indenture Trustee</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The Subordinated Indenture Trustee, other than during the occurrence and continuance of an event of default under the Subordinated Indenture, undertakes to perform only those duties as are specifically set forth in the Subordinated Indenture and, upon an event of default under the Subordinated Indenture, must use the same </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">24<br></div></div></div>
<!--End Page 43-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 44-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg20"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">degree of care as a prudent person would exercise or use in the conduct of his or her own affairs. Subject to this provision, the Subordinated Indenture Trustee is under no obligation to exercise any of the rights or powers given it by the Subordinated Indenture at the request or direction of any holder of subordinated debt securities unless the Subordinated Indenture Trustee is offered reasonable security or indemnity by that holder against the costs, expenses and liabilities that it might incur. The Subordinated Indenture Trustee is not required to spend or risk its own money or otherwise become financially liable while performing its duties unless it reasonably believes that it will be repaid or receive adequate indemnity.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The Bank of New York Mellon is a participating lender under our revolving credit agreement and provides commercial banking services to us and our affiliates. The Bank of New York Mellon Trust Company, N.A. is the Subordinated Indenture Trustee and will also act as the Senior Indenture Trustee. However, if The Bank of New York Mellon Trust Company, N.A. acquires any conflicting interest when an event of default is pending, it must (with certain exceptions) eliminate the conflict or resign.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Payment and Payment Agents</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The person in whose name a debt security subordinated is registered will be treated as the owner of such security for the purpose of receiving payment of principal and, unless otherwise indicated in an applicable prospectus supplement or pricing supplement, if any, interest on such subordinated debt security and for all other purposes.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Unless otherwise indicated in the applicable prospectus supplement or pricing supplement, if any, payment of interest on any subordinated debt securities on any interest payment date will be made to the person in whose name those subordinated debt securities (or one or more predecessor securities) are registered at the close of business on the regular record date for the interest, except as otherwise provided by the procedures of the depositary. Unless otherwise indicated in the applicable prospectus supplement or pricing supplement, if any, principal and interest on the subordinated debt securities of a particular series will be payable at the office of the paying agents that we designate, except that payments of interest may, at our option, be made by wire transfer or check mailed to the address of the person entitled thereto.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We will be required to maintain a paying agent in each place of payment for the subordinated debt securities of a particular series. Unless otherwise indicated in the applicable prospectus supplement or pricing supplement, if any, the corporate trust office of the Subordinated Indenture Trustee in the City of New York will be designated as the paying agent for payments with respect to subordinated debt securities.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">All moneys that we pay to a paying agent or the Subordinated Indenture Trustee for the payment of the principal or interest, if any, on any subordinated debt securities which remain unclaimed at the end of two years after that principal or interest has become due and payable will be repaid to us, and the holder of the security thereafter may look only to us for payment thereof.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Unless otherwise indicated in an applicable prospectus supplement or pricing supplement, if any, interest shall be computed, for fixed rate securities, on the basis of a 360-day year comprised of twelve 30-day months, and, for variable rate securities, on the basis of the actual number of days in the interest period divided by 360.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Governing Law</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The Subordinated Indenture and subordinated debt securities will be governed by and construed in accordance with the law of the State of New York (without regard to conflicts of laws principles thereof).</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">25<br></div></div></div>
<!--End Page 44-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 45-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg21"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDOC"><!--Anchor--></a>DESCRIPTION OF COMMON STOCK</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">General</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The following summary describes the material provisions of our common stock. The summary in this prospectus is not complete. We urge you to read our Restated Certificate of Incorporation of Occidental Petroleum Corporation, as amended (&#8220;Certificate of Incorporation&#8221;), and our Amended and Restated By-laws of Occidental Petroleum Corporation (&#8220;Bylaws&#8221;), which are incorporated herein by reference as exhibits to the registration statement of which this prospectus is a part.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Our Certificate of Incorporation authorizes our board of directors, without further stockholder action, to provide for the issuance of up to 1,500,000,000 shares of common stock, par value $0.20 per share. The common stock will, when issued, be fully paid and nonassessable.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Each prospectus supplement may describe certain United States federal income tax considerations applicable to the purchase, holding and disposition of the common stock that the prospectus supplement covers.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Dividend Rights</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Subject to the dividend rights of the holders of any outstanding series of preferred stock, the holders of shares of common stock will be entitled to receive dividends when, as and if declared by our board of directors. We will pay those dividends either in cash, shares of common stock or otherwise, at the rate and on the date or dates as declared by our board of directors. Accruals of dividends will not bear interest. As a Delaware corporation, we are subject to statutory limitations on the declaration and payment of dividends.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Liquidation Rights</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">In the event of any voluntary or involuntary liquidation, dissolution or winding up of our affairs, holders of common stock will be entitled to share ratably in our assets that are legally available for distribution to stockholders after payment of liabilities, and after the payment in full of the amounts required to be paid to the holders of any outstanding class or series of preferred stock. Because we are a holding company, holders of common stock may not receive assets of our subsidiaries in the event of our liquidation until the claims of creditors of such subsidiaries are paid, except to the extent that we are a creditor of, and may have recognized claims against, such subsidiaries.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Voting Rights</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Each holder of common stock entitled to vote will have one vote for each one share of common stock held on all matters to be voted upon by our stockholders, including elections of directors. Except as otherwise required by law, our Certificate of Incorporation or our Bylaws, any question brought before any meeting of stockholders will be decided by the affirmative vote of a majority of the shares present in person or by proxy at the meeting and entitled to vote on the subject matter. Directors will be elected by a majority of the votes cast, unless the number of nominees exceeds the number of directors to be elected, in which case the directors will be elected by the vote of a plurality of the votes cast.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Conversion, Redemption and Preemptive Rights</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;">Holders of our common stock have no conversion, redemption, preemptive, subscription or similar rights.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Anti-Takeover Effects of our Certificate of Incorporation and Bylaws and of Delaware Law</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Our Certificate of Incorporation and our Bylaws and Delaware law contain certain provisions that may have the effect of delaying, deferring or preventing a takeover attempt that a stockholder might consider in its best interest, including those attempts that result in a premium over the market price for the shares held by stockholders. Following is a description of certain of the anti-takeover effects of such provisions.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;">Special Meetings of Stockholders.<font style="font-style: normal; font-weight: normal;"> Our Certificate of Incorporation and Bylaws currently provide that special meetings of our stockholders may be called by our board of directors or the Chairman of our board of directors. In addition, subject to certain procedural requirements contained in our Certificate of Incorporation and Bylaws, special meetings of stockholders may be called by the Secretary upon the written request of record holders of at least 15% of our outstanding common stock.</font></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">26<br></div></div></div>
<!--End Page 45-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 46-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg22"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Advance Notice Requirements for Stockholder Proposals and Director Nominations.<font style="font-style: normal; font-weight: normal;"> Our Bylaws provide that stockholders seeking to bring business before an annual meeting of stockholders, or to nominate candidates for election as directors at an annual or special meeting of stockholders, must provide timely notice to us thereof in writing within the time periods specified in our Bylaws. Our Bylaws also specify requirements as to the form and content of a stockholder&#8217;s notice. These provisions may preclude some stockholders from bringing matters before the stockholders at an annual or special meeting or from making nominations for directors at an annual or special meeting.</font></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;">Stockholder Action by Written Consent.<font style="font-style: normal; font-weight: normal;"> Stockholders are permitted to take action without a meeting by written consent, subject to certain procedures specified in our Certificate of Incorporation and Bylaws.</font></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;">Limitations on Stockholders&#8217; Ability to Change the Number of Directors.<font style="font-style: normal; font-weight: normal;"> The number of directors to serve on our board of directors is fixed by our Bylaws, and, pursuant to our Bylaws, can only be changed by resolution of our directors. In addition, our Certificate of Incorporation provides that any vacancy on our board of directors (including any vacancy resulting from an increase in the number of directors) may be filled by a majority of our board of directors then in office. These provisions limit the ability of a stockholder to appoint new directors to our board of directors, and may have the effect of discouraging an attempt to obtain control of us by means of a proxy contest or otherwise.</font></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;">Authorized but Unissued Capital Stock.<font style="font-style: normal; font-weight: normal;"> Our Certificate of Incorporation authorizes our board of directors to issue one or more series of preferred stock, and to determine, with respect to any such series of preferred stock, the number of shares to be included in any series and the designation, relative powers, preferences, rights and qualifications, limitations or restrictions of such series of preferred stock. The DGCL does not require stockholder approval for any issuance of previously authorized shares of our capital stock. However, the listing requirements of the New York Stock Exchange (&#8220;NYSE&#8221;), which will apply so long as our common stock is listed on the NYSE, require stockholder approval of certain issuances of common stock or securities convertible into or exercisable for common stock equal to or exceeding 20% of the then outstanding voting power or then outstanding number of shares of our common stock. These additional shares may be used for a variety of corporate purposes, including future public offerings, to raise additional capital or to facilitate acquisitions.</font></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">One of the effects of the existence of unissued and unreserved common stock or preferred stock may be to enable our board of directors to issue shares to persons who support current management, which issuance could render more difficult or discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise. In addition, provisions that could discourage an unsolicited tender offer or takeover proposal, such as extraordinary voting, dividend, redemption or conversion rights, could be included in a series of preferred stock.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;">No Cumulative Voting.<font style="font-style: normal; font-weight: normal;"> The DGCL provides that stockholders of a Delaware corporation are not entitled to the right to cumulate votes in the election of directors unless its certificate of incorporation provides otherwise. Our Certificate of Incorporation provides that holders of common stock do not have cumulative voting rights in the election of directors or otherwise. A cumulative voting provision could make it easier for minority stockholders to elect one or more directors to our board of directors.</font></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;">General Corporation Law of the State of Delaware.<font style="font-style: normal; font-weight: normal;"> We are a Delaware corporation that is subject to Section&#160;203 of the DGCL. Section 203 provides that, subject to certain exceptions specified in the law, a Delaware corporation shall not engage in certain &#8220;business combinations&#8221; with any &#8220;interested stockholder&#8221; for a three-year period following the time that the stockholder became an interested stockholder unless:</font></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">prior to such time, the board of directors approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">upon consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the corporation&#8217;s voting stock outstanding at the time the transaction commenced, excluding certain shares; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">at or subsequent to that time, the business combination is approved by the board of directors of the corporation and by the affirmative vote of holders of at least 66<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup>/<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">3</sub>% of the outstanding voting stock that is not owned by the interested stockholder.</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">27<br></div></div></div>
<!--End Page 46-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 47-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg23"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">A &#8220;business combination&#8221; includes certain mergers, asset or stock sales and other transactions involving the interested stockholder. Subject to certain exceptions, an &#8220;interested stockholder&#8221; is a person who, together with that person&#8217;s affiliates and associates, owns (or within the previous three years did own) 15% or more of our voting stock.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Section 203 could prohibit or delay a merger or other takeover attempt and, accordingly, may discourage attempts to acquire us.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Stock Exchange Listing</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Our common stock is listed on the NYSE under the symbol &#8220;OXY.&#8221;</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Transfer Agent and Registrar</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">EQ Shareowner Services acts as transfer agent and registrar for our common stock.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">28<br></div></div></div>
<!--End Page 47-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 48-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg24"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDOP"><!--Anchor--></a>DESCRIPTION OF PREFERRED STOCK</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">General</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The following summary describes the material provisions of our preferred stock. The summary in this prospectus is not complete. We urge you to read our Certificate of Incorporation and our Bylaws, which are incorporated herein by reference as exhibits to the registration statement of which this prospectus is a part, and the certificate of designations establishing a particular series of preferred stock which will be filed with the Secretary of State of the State of Delaware and the SEC in connection with the offering of the preferred stock.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Our Certificate of Incorporation authorizes our board of directors, without further stockholder action, to provide for the issuance of up to 50,000,000 shares of preferred stock, par value $1.00 per share, in one or more series, and to fix the number of shares to be included in any series and the designation, relative powers, preferences and rights and qualifications, limitations or restrictions of all shares of such series.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The particular terms of any series of preferred stock that we offer under this prospectus will be described in the applicable prospectus supplement relating to that series of preferred stock. Those terms may include:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the number of shares of any series and the designation to distinguish the shares of such series from the shares of all other series;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the purchase price of the preferred stock;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the voting powers, if any, and whether such voting powers are full or limited, in any such series;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the redemption provisions, if any, applicable to such series, including the redemption price or prices to be paid;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">whether dividends, if any, shall be cumulative or noncumulative, the dividend rate, or method of determining the dividend rate of such series, and the dates and preferences of dividends on such series;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the rights of such series upon our voluntary or involuntary dissolution, or upon any distribution of our assets;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the provisions, if any, pursuant to which the shares of such series are convertible into, or exchangeable for, shares of any other class or classes or of any other series of the same or any other class or classes of stock, or any other security, of ours or any other corporation, and the price or prices or the rates of exchange applicable thereto;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the right, if any, to subscribe for or to purchase any securities of ours or any other corporation;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the provisions, if any, of any sinking fund applicable to such series; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any other relative, participating, optional or other special powers, preferences, rights, qualifications, limitations or restrictions thereof.</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Each prospectus supplement may describe certain United States federal income tax considerations applicable to the purchase, holding and disposition of the preferred stock that the prospectus supplement covers.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">If the terms of any series of preferred stock being offered differ from the terms set forth in this prospectus, those terms will also be disclosed in the applicable prospectus supplement relating to that series of preferred stock.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">The preferred stock will, when issued, be fully paid and nonassessable.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;">Dividend Rights</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The preferred stock will be preferred over the common stock as to payment of dividends. Before any dividends or distributions (other than dividends or distributions payable in common stock or other stock ranking junior to that series of preferred stock as to dividends and upon liquidation) on the common stock or other stock ranking junior to that series of preferred stock as to dividends and upon liquidation shall be declared and set apart for payment or paid, the holders of shares of each series of preferred stock (unless otherwise set forth in the applicable prospectus supplement) will be entitled to receive dividends when, as and if declared by our board of directors or, if dividends are cumulative, full cumulative dividends for the current and all prior dividend periods. We will pay those dividends either in cash, shares of preferred stock, or otherwise, at the rate and on the date or </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">29<br></div></div></div>
<!--End Page 48-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 49-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg25"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">dates set forth in the applicable prospectus supplement. With respect to each series of preferred stock that has cumulative dividends, the dividends on each share of the series will be cumulative from the date of issue of the share unless some other date is set forth in the prospectus supplement relating to the series. Accruals of dividends will not bear interest. The applicable prospectus supplement will indicate the relative ranking of the particular series of the preferred stock as to the payment of dividends, as compared with then-existing and future series of preferred stock.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Rights Upon Liquidation</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The preferred stock of each series will be preferred over the common stock and other stock ranking junior to that series of preferred stock as to assets, so that the holders of that series of preferred stock (unless otherwise set forth in the applicable prospectus supplement) will be entitled to be paid, upon our voluntary or involuntary liquidation, dissolution or winding up, and before any distribution is made to the holders of common stock and other stock ranking junior to that series of preferred stock, the amount set forth in the applicable prospectus supplement. If upon any liquidation, dissolution or winding up, our net assets are insufficient to permit the payment in full of the respective amounts to which the holders of all outstanding preferred stock are entitled, our entire remaining net assets will be distributed among the holders of each series of preferred stock in amounts proportional to the full amounts to which the holders of each series are entitled, subject to the relative rankings of each series of preferred stock upon liquidation. The applicable prospectus supplement will indicate the relative ranking of the particular series of the preferred stock upon liquidation, as compared with then-existing and future series of preferred stock. Unless otherwise specified in a prospectus supplement for a series of preferred stock, after payment of the full amount of the liquidating distribution to which they are entitled, the holders of shares of preferred stock will not be entitled to any further participation in any distribution of our assets.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Conversion, Redemption or Exchange</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The shares of a series of preferred stock will be convertible or exchangeable at the option of the holder of the preferred stock, redeemable at our option or at the option of the holder, as applicable, convertible or exchangeable at our option, into another security, in each case, to the extent set forth in the applicable prospectus supplement.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Voting Rights</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The holders of each series or class of preferred stock we may issue will have no voting rights, except as required by law and as described below or in the applicable prospectus supplement. Our Board of Directors may, upon issuance of a series or class of preferred stock, grant voting rights to the holders of that series or class, which may be full or limited.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Without the affirmative vote of a majority of the shares of any class of preferred stock then outstanding, we may not:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">increase or decrease the aggregate number of authorized shares of that class&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">increase or decrease the par value of the shares of that class&#894; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">alter or change the powers, preferences or special rights of the shares of that class so as to affect them adversely.</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">If the amendment would adversely alter or change the powers, preferences or special rights of one or more series of a class of preferred stock, but not the entire class, then only the shares of the affected series will have the right to vote on the amendment.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Other</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Our Certificate of Incorporation and our Bylaws and Delaware law contain certain provisions that may have the effect of delaying, deferring or preventing a takeover attempt that a holder of our preferred stock or depositary shares might consider in its best interest, including those attempts that may result in a premium over the market price of those shares. See &#8220;Description of Common Stock&#8212;Anti-Takeover Effects of our Certificate of Incorporation and Bylaws and of Delaware Law.&#8221;</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">30<br></div></div></div>
<!--End Page 49-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 50-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg26"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDOW"><!--Anchor--></a>DESCRIPTION OF WARRANTS</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We may issue warrants to purchase any combination of our debt securities, common stock, preferred stock or other securities. We may issue warrants independently or together with other securities. Warrants sold with other securities may be attached to or separate from the other securities. We will issue warrants under one or more warrant agreements between us and a warrant agent that we will name in the prospectus supplement.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The applicable prospectus supplement will include specific terms relating to the offering. We will file the form of any warrant agreement with the SEC, and you should read the warrant agreement for provisions that may be important to you. The prospectus supplement will include some or all of the following terms:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the title of the warrants;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the aggregate number of warrants offered;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the designation, number and terms of the debt securities, common stock, preferred stock or other securities purchasable upon exercise of the warrants, and procedures by which the number of securities purchasable may be adjusted;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the exercise price of the warrants;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the dates or periods during which the warrants are exercisable;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the designation and terms of any securities with which the warrants are issued;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if the warrants are issued as a unit with another security, the date, if any, on and after which the warrants and the other security will be separately transferable;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if the exercise price is not payable in U.S. dollars, the foreign currency, currency unit or composite currency in which the exercise price is denominated;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any minimum or maximum amount of warrants that may be exercised at any one time; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any terms, procedures and limitations relating to the transferability, exchange or exercise of the warrants.</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">31<br></div></div></div>
<!--End Page 50-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 51-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg27"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDDS"><!--Anchor--></a>DESCRIPTION OF DEPOSITARY SHARES</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The following description of the terms of the depositary shares sets forth certain general terms and provisions of the depositary shares to which any prospectus supplement may relate. The particular terms of the depositary shares offered by any prospectus supplement and the extent, if any, to which these general provisions may apply to those depositary shares will be described in the prospectus supplement relating to those depositary shares. Accordingly, for a description of the terms of a particular issue of depositary shares, reference must be made to both the prospectus supplement relating thereto and to the following description.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">General</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We may, at our option, elect to offer shares of preferred stock represented by depositary shares. The shares of any series of the preferred stock underlying the depositary shares will be deposited under a separate deposit agreement between us and one or more depositaries selected by us, who we will name in the prospectus supplement.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Subject to the terms of the deposit agreement, each holder of a depositary share will be entitled, proportionately, to all the rights, preferences and privileges of the preferred stock represented by that depositary share, including dividend, voting, redemption, conversion, exchange and liquidation rights. The depositary shares will be evidenced by depositary receipts issued under the deposit agreement. Each receipt will represent the applicable interest in a number of shares of a particular series of the preferred stock, which we will describe in the prospectus supplement.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">A holder of depositary shares will be entitled to receive the whole number of shares of preferred stock underlying those depositary shares. Holders will not be entitled to receive fractional shares. If the depositary receipts delivered by the holder evidence a number of depositary shares in excess of the whole number of shares to be withdrawn, the depositary will deliver to that holder at the same time a new depositary receipt for the excess number of depositary shares.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">32<br></div></div></div>
<!--End Page 51-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 52-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg28"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDPC"><!--Anchor--></a>DESCRIPTION OF STOCK PURCHASE CONTRACTS<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">AND STOCK PURCHASE UNITS</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We may issue stock purchase contracts, including contracts obligating holders to purchase from us, and us to sell to the holders, or for us to issue in exchange for other securities, a specified number of shares of our common stock or preferred stock (or a range of numbers of shares in accordance with a predetermined formula) at a future date or dates or upon the occurrence of specified events. The price per share of common stock or preferred stock may be fixed at the time the stock purchase contracts are issued or may be determined by reference to a specific formula set forth in the stock purchase contracts.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We may issue the stock purchase contracts separately or as a part of units, often known as stock purchase units, consisting of a stock purchase contract and any combination of our senior debt securities or subordinated debt securities or any other security registered under this registration statement as described in the applicable prospectus supplement, securing the holder&#8217;s obligations to purchase the common stock or preferred stock under the stock purchase contracts.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The stock purchase contracts may require us to make periodic payments to the holders of the stock purchase units or vice versa, and those payments may be unsecured or prefunded on some basis. The stock purchase contracts may require holders to secure their obligations in a specified manner, and in specified circumstances, we may deliver newly issued prepaid stock purchase contracts, often known as prepaid securities, upon release to a holder of any collateral securing that holder&#8217;s obligations under the original stock purchase contract.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The applicable prospectus supplement will describe the terms of any stock purchase contracts or stock purchase units and, if applicable, prepaid securities. That description will not be complete. For more information, you should review the stock purchase contracts and, if applicable, the collateral arrangements and depositary arrangements relating to those stock purchase contracts or stock purchase units and any prepaid securities and the document under which the prepaid securities will be issued. We will file forms of these documents with the SEC before we issue any stock purchase contracts or stock purchase units and, if applicable, prepaid securities.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">33<br></div></div></div>
<!--End Page 52-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 53-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_205-description_pg29"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDOU"><!--Anchor--></a>DESCRIPTION OF UNITS</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">As specified in the applicable prospectus supplement, we may issue units comprised of two or more of the other securities described in this prospectus in any combination. Each unit will be issued so that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights and obligations of a holder of each included security. The applicable prospectus supplement will describe:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the designation and terms of the units and of the securities comprising the units, including whether and under what circumstances the securities comprising the units may be held or transferred separately;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a description of the terms of any unit agreement governing the units;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a description of the provisions for the payment, settlement, transfer or exchange of the units; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">whether the units will be issued in fully registered or global form.</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The unit agreement, together with the terms of the underlying securities, will be filed with the SEC in connection with the offering of the specific units.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">34<br></div></div></div>
<!--End Page 53-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 54-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_206-plan_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tPOD"><!--Anchor--></a>PLAN OF DISTRIBUTION</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We may sell the securities in and outside the United States through underwriters or dealers, directly to purchasers, through agents or a combination of these methods.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Sale Through Underwriters or Dealers</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">If we use underwriters in the sale of securities, the underwriters will acquire the securities for their own account. The underwriters may resell the securities from time to time in one or more transactions, including negotiated transactions, at a fixed public offering price or at varying prices determined at the time of sale. Underwriters may offer securities to the public either through underwriting syndicates represented by one or more managing underwriters or directly by one or more firms acting as underwriters. Unless we inform you otherwise in a prospectus supplement, the obligations of the underwriters to purchase the securities will be subject to conditions, and the underwriters will be obligated to purchase all the securities if they purchase any of them. The&#160;underwriters may change from time to time any initial public offering price and any discounts or concessions allowed or re-allowed or paid to dealers.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">During and after an offering through underwriters, the underwriters may purchase and sell the securities in the open market. These transactions may include overallotment and stabilizing transactions and purchases to cover syndicate short positions created in connection with the offering. The underwriters may also impose a penalty bid, whereby selling concessions allowed to syndicate members or other broker-dealers for the offered securities sold for their account may be reclaimed by the syndicate if such offered securities are repurchased by the syndicate in stabilizing or covering transactions. These activities may stabilize, maintain or otherwise affect the market price of the offered securities, which may be higher than the price that might otherwise prevail in the open market. If commenced, these activities may be discontinued at any time.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">If we use dealers in the sale of securities, we will sell the securities to them as principals. They may then resell those securities to the public at varying prices determined by the dealers at the time of resale. The dealers participating in any sale of the securities may be deemed to be underwriters within the meaning of the Securities Act with respect to any sale of those securities. We will include in the prospectus supplement the names of the dealers and the terms of the transaction.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Direct Sales and Sales Through Agents</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We may sell the securities directly. In that event, no underwriters or agents would be involved. We may also sell the securities through agents we designate from time to time. In a prospectus supplement, we will name any agent involved in the offer or sale of the securities, and we will describe any commissions payable by us to the agent. Unless we inform you otherwise in such prospectus supplement, any agent will agree to use its reasonable best efforts to solicit purchases for the period of its appointment.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We may sell the securities directly to institutional investors or others who may be deemed to be underwriters within the meaning of the Securities Act with respect to any sale of those securities. We will describe the terms of any such sales in a prospectus supplement.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Delayed Delivery Contracts</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">If we so indicate in a prospectus supplement, we may authorize agents, underwriters or dealers to solicit offers from certain types of institutions to purchase securities from us at the public offering price under delayed delivery contracts. These contracts would provide for payment and delivery on a specified date in the future. The&#160;contracts would be subject only to those conditions described in such prospectus supplement. Such prospectus supplement will describe the commission payable for solicitation of those contracts.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">General Information</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We may have agreements with the agents, dealers and underwriters to indemnify them against civil liabilities, including liabilities under the Securities Act, or to contribute with respect to payments that the agents, dealers or underwriters may be required to make. Agents, dealers and underwriters may engage in transactions with us or perform services for us in the ordinary course of their businesses.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">35<br></div></div></div>
<!--End Page 54-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 55-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20044010x1_424b2_207-legal_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tLM"><!--Anchor--></a>LEGAL MATTERS</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Unless otherwise indicated in the applicable prospectus supplement, the validity of the securities offered under this prospectus will be passed upon for us by Cravath, Swaine &amp; Moore LLP, New York, New York. Additional legal matters may be passed on for us, or any underwriters, dealers or agents, by counsel we will name in the applicable prospectus supplement.</div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;"><a name="tE"><!--Anchor--></a>EXPERTS</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The consolidated financial statements of Occidental Petroleum Corporation and subsidiaries as of December&#160;31, 2021 and 2020, and for each of the years in the three-year period ended December&#160;31, 2021, and management&#8217;s assessment of the effectiveness of internal control over financial reporting as of December&#160;31, 2021, have been incorporated by reference herein in reliance upon the reports of KPMG LLP, an independent registered public accounting firm, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Certain information with respect to the oil and gas reserves associated with Occidental&#8217;s oil and gas properties is confirmed in the process review letter of Ryder Scott Company, L.P., independent petroleum engineering consultants, and has been incorporated by reference into this document, upon the authority of said firm as experts with respect to the matters covered by such process review letter and in giving such process review letter.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">36<br></div></div></div>
<!--End Page 55-->
</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>ny20044010x1_ex107.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Sat Mar 01 23:18:20 UTC 2025 -->
<html xmlns:compsci="http://compsciresources.com" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title> </title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc. Document created using Broadridge PROfile 25.1.1.5279 Copyright 1995 - 2025 Broadridge -->

<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;"><div>
  </div><div>
    <div style="text-align: right; font-weight: bold;">
      <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"/>Exhibit 107</div>
    <div><br/>
    </div>
    <div style="text-align: center; font-weight: bold;">Calculation of Filing Fee Table</div>
    <div><br/>
    </div>
    <div style="text-align: center; font-weight: bold;">FORM <span style="-sec-ix-hidden: hidden-fact-0">424(b)(2)</span></div>
    <div style="text-align: center;">(Form Type)</div>
    <div><br/>
    </div>
    <div style="text-align: center; font-weight: bold;"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-289">Occidental Petroleum Corporation</ix:nonNumeric></div>
    <div style="text-align: center;">(Exact Name of Registrant as Specified in its Charter)</div>
    <div><br/>
    </div>
    <div style="text-align: center;"><span style="text-decoration:underline">Table 1: Newly Registered and Carry Forward Securities</span></div>
    <div><br/>
    </div>
    <table cellpadding="0" id="z150a9c572d894929884e1decec05c9b4" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0px;"> <tr> <td style="width: 8.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 4.9%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: center; font-weight: bold;">Note #</div> </td> <td style="width: 6.02%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: center; font-weight: bold;">Security</div> <div style="text-align: center; font-weight: bold;">Type</div> </td> <td style="width: 5.98%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: center; font-weight: bold;">Security</div> <div style="text-align: center; font-weight: bold;">Class</div> <div style="text-align: center; font-weight: bold;">Title</div> </td> <td style="width: 7.68%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: center; font-weight: bold;">Fee</div> <div style="text-align: center; font-weight: bold;">Calculation</div> <div style="text-align: center; font-weight: bold;">or Carry</div> <div style="text-align: center; font-weight: bold;">Forward Rule</div> </td> <td style="width: 7.76%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: center; font-weight: bold;">Amount</div> <div style="text-align: center; font-weight: bold;">Registered</div> </td> <td style="width: 6.98%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: center; font-weight: bold;">Proposed</div> <div style="text-align: center; font-weight: bold;">Maximum</div> <div style="text-align: center; font-weight: bold;">Offering Price</div> <div style="text-align: center; font-weight: bold;">Per Share</div> </td> <td style="width: 11.23%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: center; font-weight: bold;">Maximum</div> <div style="text-align: center; font-weight: bold;">Aggregate</div> <div style="text-align: center; font-weight: bold;">Offering Price</div> </td> <td style="width: 6.71%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: center; font-weight: bold;">Fee</div> <div style="text-align: center; font-weight: bold;">Rate</div> </td> <td style="width: 8.14%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: center; font-weight: bold;">Amount of</div> <div style="text-align: center; font-weight: bold;">Registration Fee</div> </td> <td style="width: 6.06%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: center; font-weight: bold;">Carry Forward Form Type</div> </td> <td colspan="2" style="width: 6.06%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: center; font-weight: bold;">Carry Forward File Number</div> </td> <td style="width: 6.06%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: center; font-weight: bold;">Carry Forward Initial Effective Date</div> </td> <td style="width: 7.6%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: center; font-weight: bold;">Previously Paid in Connection with Unsold Securities to be Carried Forward</div> </td> </tr> <tr> <td colspan="15" style="width: 100%; vertical-align: bottom; background-color: #D9D9D9; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: center;">Newly Registered Securities</div> </td> </tr> <tr> <td style="width: 8.81%; vertical-align: middle; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 4.9%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 6.02%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 5.98%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 7.68%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 6.98%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 11.23%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 6.71%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 8.14%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td colspan="2" style="width: 6.18%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 5.93%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 6.06%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 7.6%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> </tr> <tr> <td style="width: 8.81%; vertical-align: middle; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: center;"><ix:nonNumeric contextRef="c1" format="ixt:fixed-false" name="ffd:PrevslyPdFlg" id="ixv-290">Fees to Be Paid</ix:nonNumeric></div> </td> <td style="width: 4.9%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: center;">1</div> </td> <td style="width: 6.02%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: center;"><ix:nonNumeric contextRef="c1" name="ffd:OfferingSctyTp" id="ixv-291">Equity</ix:nonNumeric></div> </td> <td style="width: 5.98%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: center;"><ix:nonNumeric contextRef="c1" name="ffd:OfferingSctyTitl" id="ixv-292">Common Stock, par value $0.20 per share</ix:nonNumeric></div> </td> <td style="width: 7.68%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: center;"><ix:nonNumeric contextRef="c1" format="ixt:fixed-true" name="ffd:Rule457rFlg" id="ixv-293">457(r)</ix:nonNumeric></div> </td> <td style="width: 7.76%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: right;"><ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="ffd:AmtSctiesRegd" scale="0" unitRef="shares" id="ixv-294">111,414,652</ix:nonFraction></div> </td> <td style="width: 6.98%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: right;">$<ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="ffd:MaxOfferingPricPerScty" scale="0" unitRef="shares" id="ixv-295">22.00</ix:nonFraction></div> </td> <td style="width: 11.23%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: right;">$<ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="ffd:MaxAggtOfferingPric" scale="0" unitRef="usd" id="ixv-296">2,451,122,344.00</ix:nonFraction></div> </td> <td style="width: 6.71%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: right;"><ix:nonFraction contextRef="c1" decimals="7" format="ixt:num-dot-decimal" name="ffd:FeeRate" scale="0" unitRef="pure" id="ixv-297">0.0001531</ix:nonFraction></div> </td> <td style="width: 8.14%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: right;">$<ix:nonFraction contextRef="c1" decimals="2" format="ixt:num-dot-decimal" name="ffd:FeeAmt" scale="0" unitRef="usd" id="ixv-298">375,266.83</ix:nonFraction></div> </td> <td colspan="2" style="width: 6.18%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 5.93%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 6.06%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 7.6%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> </tr> <tr> <td style="width: 8.81%; vertical-align: middle; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: center;">Fees Previously Paid</div> </td> <td style="width: 4.9%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 6.02%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 5.98%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 7.68%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 6.98%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 11.23%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 6.71%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 8.14%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td colspan="2" style="width: 6.18%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 5.93%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 6.06%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 7.6%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> </tr> <tr> <td colspan="15" style="width: 100%; vertical-align: middle; background-color: #D9D9D9; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: center;">Carry Forward Securities</div> </td> </tr> <tr> <td style="width: 8.81%; vertical-align: middle; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;"> <div style="text-align: center;">Carry Forward Securities</div> </td> <td style="width: 4.9%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 6.02%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 5.98%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 7.68%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 6.98%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 11.23%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 6.71%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 8.14%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td colspan="2" style="width: 6.18%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 5.93%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 6.06%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 7.6%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> </tr> <tr> <td style="width: 8.81%; vertical-align: middle; border-left: #000000 2px solid; border-top: #000000 2px solid;">&#160;</td> <td style="width: 4.9%; vertical-align: top; border-top: #000000 2px solid;">&#160;</td> <td style="width: 6.02%; vertical-align: top; border-top: #000000 2px solid;">&#160;</td> <td style="width: 5.98%; vertical-align: top; border-top: #000000 2px solid;">&#160;</td> <td colspan="2" style="width: 15.43%; vertical-align: top; border-top: #000000 2px solid;"> <div style="text-align: right;">Total Offering Amounts:</div> </td> <td style="width: 6.98%; vertical-align: top; border-top: #000000 2px solid;">&#160;</td> <td style="width: 11.23%; vertical-align: top; border-top: #000000 2px solid;"> <div style="text-align: right;">$<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="ffd:TtlOfferingAmt" scale="0" unitRef="usd" id="ixv-299">2,451,122,344.00</ix:nonFraction></div> </td> <td style="width: 6.71%; vertical-align: bottom; border-top: #000000 2px solid;">&#160;</td> <td style="width: 8.14%; vertical-align: top; border-top: #000000 2px solid;"> <div style="text-align: right;">$<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ffd:TtlFeeAmt" scale="0" unitRef="usd" id="ixv-300">375,266.83</ix:nonFraction></div> </td> <td colspan="2" style="width: 6.18%; vertical-align: top; border-top: #000000 2px solid;">&#160;</td> <td style="width: 5.93%; vertical-align: top; border-top: #000000 2px solid;">&#160;</td> <td style="width: 6.06%; vertical-align: top; border-top: #000000 2px solid;">&#160;</td> <td style="width: 7.6%; vertical-align: top; border-right: #000000 2px solid; border-top: #000000 2px solid;">&#160;</td> </tr> <tr> <td rowspan="1" style="width: 8.81%; vertical-align: middle; border-left: #000000 2px solid;">&#160;</td> <td rowspan="1" style="width: 4.9%; vertical-align: top;">&#160;</td> <td rowspan="1" style="width: 6.02%; vertical-align: top;">&#160;</td> <td rowspan="1" style="width: 5.98%; vertical-align: top;">&#160;</td> <td colspan="2" rowspan="1" style="width: 15.43%; vertical-align: top;">&#160;</td> <td rowspan="1" style="width: 6.98%; vertical-align: top;">&#160;</td> <td rowspan="1" style="width: 11.23%; vertical-align: top;">&#160;</td> <td rowspan="1" style="width: 6.71%; vertical-align: bottom;">&#160;</td> <td rowspan="1" style="width: 8.14%; vertical-align: top;">&#160;</td> <td colspan="2" rowspan="1" style="width: 6.18%; vertical-align: top;">&#160;</td> <td rowspan="1" style="width: 5.93%; vertical-align: top;">&#160;</td> <td rowspan="1" style="width: 6.06%; vertical-align: top;">&#160;</td> <td rowspan="1" style="width: 7.6%; vertical-align: top; border-right: #000000 2px solid;">&#160;</td> </tr> <tr> <td style="width: 8.81%; vertical-align: middle; border-left: #000000 2px solid;">&#160;</td> <td style="width: 4.9%; vertical-align: top;">&#160;</td> <td style="width: 6.02%; vertical-align: top;">&#160;</td> <td style="width: 5.98%; vertical-align: top;">&#160;</td> <td colspan="2" style="width: 15.43%; vertical-align: top;"> <div style="text-align: right;">Total Fees Previously Paid:</div> </td> <td style="width: 6.98%; vertical-align: top;">&#160;</td> <td style="width: 11.23%; vertical-align: top;">&#160;</td> <td style="width: 6.71%; vertical-align: bottom;">&#160;</td> <td style="width: 8.14%; vertical-align: top;"> <div style="text-align: right;">$<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ffd:TtlPrevslyPdAmt" scale="0" unitRef="usd" id="ixv-301">0.00</ix:nonFraction></div> </td> <td colspan="2" style="width: 6.18%; vertical-align: top;">&#160;</td> <td style="width: 5.93%; vertical-align: top;">&#160;</td> <td style="width: 6.06%; vertical-align: top;">&#160;</td> <td style="width: 7.6%; vertical-align: top; border-right: #000000 2px solid;">&#160;</td> </tr> <tr> <td rowspan="1" style="width: 8.81%; vertical-align: middle; border-left: #000000 2px solid;">&#160;</td> <td rowspan="1" style="width: 4.9%; vertical-align: top;">&#160;</td> <td rowspan="1" style="width: 6.02%; vertical-align: top;">&#160;</td> <td rowspan="1" style="width: 5.98%; vertical-align: top;">&#160;</td> <td colspan="2" rowspan="1" style="width: 15.43%; vertical-align: top;">&#160;</td> <td rowspan="1" style="width: 6.98%; vertical-align: top;">&#160;</td> <td rowspan="1" style="width: 11.23%; vertical-align: top;">&#160;</td> <td rowspan="1" style="width: 6.71%; vertical-align: bottom;">&#160;</td> <td rowspan="1" style="width: 8.14%; vertical-align: top;">&#160;</td> <td colspan="2" rowspan="1" style="width: 6.18%; vertical-align: top;">&#160;</td> <td rowspan="1" style="width: 5.93%; vertical-align: top;">&#160;</td> <td rowspan="1" style="width: 6.06%; vertical-align: top;">&#160;</td> <td rowspan="1" style="width: 7.6%; vertical-align: top; border-right: #000000 2px solid;">&#160;</td> </tr> <tr> <td style="width: 8.81%; vertical-align: middle; border-left: #000000 2px solid;">&#160;</td> <td style="width: 4.9%; vertical-align: top;">&#160;</td> <td style="width: 6.02%; vertical-align: top;">&#160;</td> <td style="width: 5.98%; vertical-align: top;">&#160;</td> <td colspan="2" style="width: 15.43%; vertical-align: top;"> <div style="text-align: right;">Total Fee Offsets:</div> </td> <td style="width: 6.98%; vertical-align: top;">&#160;</td> <td style="width: 11.23%; vertical-align: top;">&#160;</td> <td style="width: 6.71%; vertical-align: bottom;">&#160;</td> <td style="width: 8.14%; vertical-align: top;"> <div style="text-align: right;">$<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ffd:TtlOffsetAmt" scale="0" unitRef="usd" id="ixv-302">0.00</ix:nonFraction></div> </td> <td colspan="2" style="width: 6.18%; vertical-align: top;">&#160;</td> <td style="width: 5.93%; vertical-align: top;">&#160;</td> <td style="width: 6.06%; vertical-align: top;">&#160;</td> <td style="width: 7.6%; vertical-align: top; border-right: #000000 2px solid;">&#160;</td> </tr> <tr> <td rowspan="1" style="width: 8.81%; vertical-align: middle; border-left: #000000 2px solid;">&#160;</td> <td rowspan="1" style="width: 4.9%; vertical-align: top;">&#160;</td> <td rowspan="1" style="width: 6.02%; vertical-align: top;">&#160;</td> <td rowspan="1" style="width: 5.98%; vertical-align: top;">&#160;</td> <td colspan="2" rowspan="1" style="width: 15.43%; vertical-align: top;">&#160;</td> <td rowspan="1" style="width: 6.98%; vertical-align: top;">&#160;</td> <td rowspan="1" style="width: 11.23%; vertical-align: top;">&#160;</td> <td rowspan="1" style="width: 6.71%; vertical-align: bottom;">&#160;</td> <td rowspan="1" style="width: 8.14%; vertical-align: top;">&#160;</td> <td colspan="2" rowspan="1" style="width: 6.18%; vertical-align: top;">&#160;</td> <td rowspan="1" style="width: 5.93%; vertical-align: top;">&#160;</td> <td rowspan="1" style="width: 6.06%; vertical-align: top;">&#160;</td> <td rowspan="1" style="width: 7.6%; vertical-align: top; border-right: #000000 2px solid;">&#160;</td> </tr> <tr> <td style="width: 8.81%; vertical-align: middle; border-left: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 4.9%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 6.02%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 5.98%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td> <td colspan="2" style="width: 15.43%; vertical-align: top; border-bottom: #000000 2px solid;"> <div style="text-align: right;">Net Fee Due:</div> </td> <td style="width: 6.98%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 11.23%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 6.71%; vertical-align: bottom; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 8.14%; vertical-align: top; border-bottom: #000000 2px solid;"> <div style="text-align: right;">$<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ffd:NetFeeAmt" scale="0" unitRef="usd" id="ixv-303">375,266.83</ix:nonFraction></div> </td> <td colspan="2" style="width: 6.18%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 5.93%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 6.06%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td> <td style="width: 7.6%; vertical-align: top; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td> </tr> </table>
    <div>
      <div><br/>
      </div>
      <div>
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"/> </div>
      <div><br/>
      </div>
    </div>
    <ix:nonNumeric contextRef="c1" continuedAt="_OfferingNote-c1_cont_1" escape="true" name="ffd:OfferingNote" id="ixv-264"><div style="font-weight: bold;">Offering Note</div></ix:nonNumeric>
    <ix:continuation continuedAt="_OfferingNote-c1_cont_2" id="_OfferingNote-c1_cont_1"><div style="margin: 0px 0px 0px 20px;">1&#160;&#160; <br/>
    </div></ix:continuation>

    <ix:continuation continuedAt="_OfferingNote-c1_cont_3" id="_OfferingNote-c1_cont_2"><div style="margin: -15px 0px 0px 40px;">1.a. The &#8220;Amount Registered&#8221; includes 74,020,695 shares of the registrant&#8217;s common stock, par value $0.20 per share (the &#8220;Common Stock&#8221;), underlying unexercised Warrants (as defined in the prospectus supplement to which this exhibit is attached) as of the date of the prospectus supplement to which this exhibit is attached and 37,393,957 shares of Common Stock issued upon exercise of Warrants between July 29, 2022 and the date of this prospectus supplement pursuant to the prospectus in the registrant&#8217;s Registration Statement on Form S-3ASR (File No. <ix:nonNumeric contextRef="c0" name="ffd:RegnFileNb" id="ixv-304">333-266420</ix:nonNumeric>) (the &#8220;Registration Statement&#8221;) for which a filing fee has not previously been paid. The initial exercise price of the Warrants of $22.00 is being used to calculate the filing fee in accordance with Rule 457(g) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). This &#8220;Calculation of Filing Fee&#8221; table shall be deemed to update the &#8220;Calculation of Filing Fee&#8221; table in the Registration Statement.</div></ix:continuation><div><br/>
    </div>
    <ix:continuation id="_OfferingNote-c1_cont_3"><div style="margin: 0px 0px 0px 40px;">1.b. Pursuant to Rule 416 under the Securities Act of 1933, the Common Stock being registered hereunder includes such indeterminable number of shares of Common Stock that may be offered or issued in connection
      with any stock split, stock dividend or similar transactions.</div></ix:continuation>
    <div><br/>
    </div>
    <ix:nonNumeric contextRef="c0" continuedAt="_NrrtvDsclsr-c0_cont_1" escape="true" name="ffd:NrrtvDsclsr" id="ixv-277"><div style="text-align: center; font-weight: bold;">Narrative Disclosure</div></ix:nonNumeric>
    <div><br/>
    </div>

    <ix:continuation id="_NrrtvDsclsr-c0_cont_1"><div>The maximum aggregate amount of the securities to which the prospectus relates is <ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="ffd:NrrtvMaxAggtAmt" scale="0" unitRef="shares" id="ixv-305">74,020,695</ix:nonFraction> shares of Common Stock. The prospectus is a <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="ffd:FnlPrspctsFlg" id="ixv-306">final prospectus</ix:nonNumeric> for the related offering.</div></ix:continuation><div> <br/>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"/> </div>
  </div><div>
</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" id="hidden-fact-0" name="ffd:SubmissnTp">424B2</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-310">0000797468</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:FeeExhibitTp" id="ixv-311">EX-FILING FEES</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:FormTp" id="ixv-312">S-3</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd" xlink:type="simple"/></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><xbrli:context xmlns="" id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797468</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-03-03</xbrli:startDate>
    <xbrli:endDate>2025-03-03</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1">
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uqgO9qQHmt9BQ98lPQIywLyErl6i3VNS4P6q4slFPW79oQz+5WCYZXkggpF+KpZSFKXmVak5t1DRPhRV9hE2M0F46aug7vKZt7rSJHQml8BEMIA0tNIEED6xcFiw28G647F6YHdud+x05BGBpGiVm0eSOHZVEbVOIFewpiGkKA4mJk7vSw7EMXzMjJ5CmyeWZuPuKM2eGyeaY/Wp6tuE1j/9tro5jBMhp4Z0GRGKICpmFmtXWcaTo0NQwh+LLVCU4vn84olHDE3YNwaNv2QYN/n1Z+X1VjfQjz+6kU0M9Zl9vhYiFNh3sNcfY24qrgI8=] CSR-->
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797468</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>1</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-03-03</xbrli:startDate>
    <xbrli:endDate>2025-03-03</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit xmlns="" id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo_oxy2.jpg
<TEXT>
begin 644 logo_oxy2.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
M                                                          !8
M65H@        ]M8  0    #3+71E>'0     0V]P>7)I9VAT($AE=VQE='0@
M4&%C:V%R9"P@,C P- !S9C,R       !#$0   7?___S)@  !Y0  /V/___[
MH?___:(   /;  # =?_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! ?_  !$( -H U@,!(@ "$0$#$0'_Q  ?   !!0$!
M 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!    7T!
M @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F
M)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH
M**^!OVTO^"EG[)7[".A2W7QK^(ME/XVGMA/H?PC\'RV6O_$[7A)',]O+%X<2
M\@.CZ9.T#Q+KGB*YTC1A*5B%\TSI$W\D_P"UW_P<0_M7?'^35/"WP L[7]FO
MX;W<DMO%>Z//'K?Q5U*R+21J+_Q?-%'9:"9XF222#PSIEI=P2 Q)K=S#N,GZ
M#PGX9\5<7^SK8'!K!Y;.23S3,'+#X5QNKNA'EE7Q;LW9X>E.GS+EG5I[KR\?
MF^"R]-5JG-52;5&DE.IM=<RNHPOT<VKZVO9G]L'QG_:7^ /[/&EG6/C;\7?
MOPWM/):>&'Q)KMK;:K>QK_T#-"A:?6]5D8_+'#ING74LKD)&CN0I_(WXH?\
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MM.B>(/VE-5LR+VX8%XKMO@_I$LVVUA'$4'C/Q#:O<2?OY=&T2VQ8:X_Y$_\
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M@=/#Q^I/K69-_P &C'[8,BL%_:9_9U!..ME\1<8Z=O#9[5_?]17UG^OO$?\
MS_PW_A)22Z+9+LNG^5L(86A#X8=GK*;O;UD?Y^9_X-$/VQB"!^TU^SCR.]I\
M1_\ YF*I-_P:#_MDL<_\--_LWC_MU^)/_P RU?Z#-%2^.^(7O7P__A+2\O+R
M_'T-N2"5E%+YR_5_U<_SXF_X-!/VR6.?^&G/V;QQC_CT^)/_ ,R])_Q"!?MD
M_P#1SO[-_P#X"?$G_P"9>O\ 0>HK"7&6=RWJ8=_]R\.GS(="D]XW_P"WI?HS
M_/NL?^#1/]M739UGL_VH_P!G*%U.2%M?B3L<9!VNO_"+[6!P."*_LI_X)O?
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M@TW3(+6VA7<CR2?>L.DZ5;A1;Z9I\ 7[HAL[:(+CIM"1KC\*Q/ 8 \#^# N
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MK_LV?M'V3$>1;_'#2+J,?-D2WG@+1HIC@L5P4L8,;5#$@[F8;0O],]?S+_\
M!L5;[?V;/VC[K=GSOCAI%OLQ]W[-X"T:3=G/._[5C&!C9G)W<?TT5^W\!W_U
M2R:__/G$?=]=Q-OP/\O?I3\O_$P'B7RVM_;&"O;^;^Q,KY_FY\S?=W9^)?\
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M3PUC91J8C*\;4I1>)P&*Y>6:<&XXG+LPHJG*I!4,9AY4:\'&C_5?_P %D/\
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M6Q6$C5G'#8BM@\UR586M6HI^SJ5<,L1B(T*DHN=*->M&$HQJU%+\5:_T/?\
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M*S*THR2<7;ZS=73U5DT[II,Y9U:\5[OE;1/MT_/_ (+O_;5%_P ';US( ?\
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MO_A1KNJO$(CXG\%JH2U\Z5KC6?#$FDZSN>ZDU**T_'_1-2!VVTQ (($;D_\
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MDZD)K>\TZ_@)>PUSP]K%E);ZIX?U_3)OWUAJVE75M=PG?"SR6LUQ!+_GA_\
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HJ4E_R\LYU=K?Q*CE/7K[P4445\N>@%%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>logo_oxy3.jpg
<TEXT>
begin 644 logo_oxy3.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH
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M&5U.=6=;$UG*4_9TZ%*B4445XYZH4444 %%%% !1110 4444 %%%% !1110
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M)X9<_P"MK4-Q;V]W#);W4$-S;S*4E@N(DFAE0\E9(I%9'4D#*LI''2OS'/\
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M,QC-I<\8<7X:I&,M+J,Y</4W)+6S<(-Z>ZKZ?Y.M%?ZQ7_#/OP$_Z(A\(?\
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MT,-S#-;W$,5Q;W$4D,\$T:2PS0RH8Y89HI R212(S))&ZLCHQ5@02*_S)/\
M@K-^P]J/["7[9'Q"^'.F:/=V?P@\:7=Q\1O@7J;1RM87'P^\17<TX\,V]W)<
MWLDU]\/-7-_X)OEOKD:K=6^D:;XAN[:"T\0Z<\_^G!7Y5_\ !7O_ ()\6/\
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MX1US4Q# E[JLT4,:+_45^R?_ ,'.G[.WCV/2_#G[7'PU\2? 7Q&T,,-_\0?
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M'#TZ::OT:/$QN9YEF,E/,,PQN/FG=3QN+KXJ2=K74J]2HT[:73V"OJ+]D?\
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%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45880707394576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Mar. 03, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000797468<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Occidental Petroleum Corporation<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-266420<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45880707324448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Mar. 03, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock, par value $0.20 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">111,414,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit | shares</a></td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price | $</a></td>
<td class="nump">$ 2,451,122,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee | $</a></td>
<td class="nump">$ 375,266.83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text"><div style="font-weight: bold;">Offering Note</div><div style="margin: 0px 0px 0px 20px;">1&#160;&#160; <br/>
    </div><div style="margin: -15px 0px 0px 40px;">1.a. The &#8220;Amount Registered&#8221; includes 74,020,695 shares of the registrant&#8217;s common stock, par value $0.20 per share (the &#8220;Common Stock&#8221;), underlying unexercised Warrants (as defined in the prospectus supplement to which this exhibit is attached) as of the date of the prospectus supplement to which this exhibit is attached and 37,393,957 shares of Common Stock issued upon exercise of Warrants between July 29, 2022 and the date of this prospectus supplement pursuant to the prospectus in the registrant&#8217;s Registration Statement on Form S-3ASR (File No. 333-266420) (the &#8220;Registration Statement&#8221;) for which a filing fee has not previously been paid. The initial exercise price of the Warrants of $22.00 is being used to calculate the filing fee in accordance with Rule 457(g) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). This &#8220;Calculation of Filing Fee&#8221; table shall be deemed to update the &#8220;Calculation of Filing Fee&#8221; table in the Registration Statement.</div><div style="margin: 0px 0px 0px 40px;">1.b. Pursuant to Rule 416 under the Securities Act of 1933, the Common Stock being registered hereunder includes such indeterminable number of shares of Common Stock that may be offered or issued in connection
      with any stock split, stock dividend or similar transactions.</div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45880708586736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Mar. 03, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 2,451,122,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">375,266.83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvDsclsr', window );">Narrative Disclosure</a></td>
<td class="text"><div style="text-align: center; font-weight: bold;">Narrative Disclosure</div><div>The maximum aggregate amount of the securities to which the prospectus relates is 74,020,695 shares of Common Stock. The prospectus is a final prospectus for the related offering.</div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 375,266.83<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtAmt', window );">Narrative - Max Aggregate Offering Amount | shares</a></td>
<td class="nump">74,020,695<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvDsclsr">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvDsclsr</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ N#UC6E)Q;[5= 0  2 ,   \
M  !X;"]W;W)K8F]O:RYX;6RUDMU*PT 0A5\E[ .86G_ TO3&4A5$BY7>;Y*)
M&=S="3,;:WUZ)PG!@"#>]&HS9Y:3;\[.\D#\GA.])Y_>!<E,'6.S2%,I:O!6
MSJB!H)V*V-NH);^ETC#84FJ Z%TZG\VN4V\QF-5R]-IR.BTH0A&1@HJ=L$<X
MR$^_*Y,/%,S183QFIO]V8!*/ 3U^09F9F4FDIL,],7Y1B-;M"B;G,G,^-/;
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MS5;]Y<!ZGM_BUK[$=6@OR?7K -972#Y02P,$%     @ N#UC6J;\2ELC 0
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( +@]8UJ17B>G<0(  -8&   8
M          " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " "X/6-:HR>Z>2 %  !%#@  &               @(&U"@  >&PO=V]R
M:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ N#UC6DGH)$P& P  70@
M !@              ("!"Q   'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+
M 0(4 Q0    ( +@]8UH3GP9,%P,  !81   -              "  4<3  !X
M;"]S='EL97,N>&UL4$L! A0#%     @ N#UC6I>*NQS     $P(   L
M         ( !B18  %]R96QS+RYR96QS4$L! A0#%     @ N#UC6E)Q;[5=
M 0  2 ,   \              ( !<A<  'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( +@]8UJ[;.KLN@   !H#   :              "  ?P8  !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( +@]8UJF_$I;(P$
M -\$   3              "  >X9  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@     +  L R@(  $(;      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ny20044010x1_ex107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ny20044010x1_ex107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ny20044010x1_ex107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="ny20044010x1_ex107.htm">ny20044010x1_ex107.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/ffd/2024q2</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ny20044010x1_ex107.htm": {
   "dts": {
    "inline": {
     "local": [
      "ny20044010x1_ex107.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2024": 1,
    "http://xbrl.sec.gov/ffd/2024q2": 3
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024q2": 22,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20044010x1_ex107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20044010x1_ex107.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20044010x1_ex107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20044010x1_ex107.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20044010x1_ex107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20044010x1_ex107.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001140361-25-006655-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-25-006655-xbrl.zip
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;-RYH=&U02P4&      $  0!$    H1

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>ny20044010x1_ex107_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
      xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797468</identifier>
        </entity>
        <period>
            <startDate>2025-03-03</startDate>
            <endDate>2025-03-03</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797468</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-03</startDate>
            <endDate>2025-03-03</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-289">Occidental Petroleum Corporation</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c1" id="ixv-290">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c1" id="ixv-291">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c1" id="ixv-292">Common Stock, par value $0.20 per share</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="c1" id="ixv-293">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="c1"
      decimals="INF"
      id="ixv-294"
      unitRef="shares">111414652</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c1"
      decimals="INF"
      id="ixv-295"
      unitRef="shares">22</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric contextRef="c1" decimals="INF" id="ixv-296" unitRef="usd">2451122344</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate contextRef="c1" decimals="7" id="ixv-297" unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt contextRef="c1" decimals="2" id="ixv-298" unitRef="usd">375266.83</ffd:FeeAmt>
    <ffd:TtlOfferingAmt contextRef="c0" decimals="INF" id="ixv-299" unitRef="usd">2451122344</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt contextRef="c0" decimals="2" id="ixv-300" unitRef="usd">375266.83</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt contextRef="c0" decimals="2" id="ixv-301" unitRef="usd">0</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt contextRef="c0" decimals="2" id="ixv-302" unitRef="usd">0</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt contextRef="c0" decimals="2" id="ixv-303" unitRef="usd">375266.83</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c1" id="ixv-264">&lt;div style="font-weight: bold;"&gt;Offering Note&lt;/div&gt;&lt;div style="margin: 0px 0px 0px 20px;"&gt;1&#160;&#160; &lt;br/&gt;
    &lt;/div&gt;&lt;div style="margin: -15px 0px 0px 40px;"&gt;1.a. The &#x201c;Amount Registered&#x201d; includes 74,020,695 shares of the registrant&#x2019;s common stock, par value $0.20 per share (the &#x201c;Common Stock&#x201d;), underlying unexercised Warrants (as defined in the prospectus supplement to which this exhibit is attached) as of the date of the prospectus supplement to which this exhibit is attached and 37,393,957 shares of Common Stock issued upon exercise of Warrants between July 29, 2022 and the date of this prospectus supplement pursuant to the prospectus in the registrant&#x2019;s Registration Statement on Form S-3ASR (File No. 333-266420) (the &#x201c;Registration Statement&#x201d;) for which a filing fee has not previously been paid. The initial exercise price of the Warrants of $22.00 is being used to calculate the filing fee in accordance with Rule 457(g) of the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;). This &#x201c;Calculation of Filing Fee&#x201d; table shall be deemed to update the &#x201c;Calculation of Filing Fee&#x201d; table in the Registration Statement.&lt;/div&gt;&lt;div style="margin: 0px 0px 0px 40px;"&gt;1.b. Pursuant to Rule 416 under the Securities Act of 1933, the Common Stock being registered hereunder includes such indeterminable number of shares of Common Stock that may be offered or issued in connection
      with any stock split, stock dividend or similar transactions.&lt;/div&gt;</ffd:OfferingNote>
    <ffd:RegnFileNb contextRef="c0" id="ixv-304">333-266420</ffd:RegnFileNb>
    <ffd:NrrtvDsclsr contextRef="c0" id="ixv-277">&lt;div style="text-align: center; font-weight: bold;"&gt;Narrative Disclosure&lt;/div&gt;&lt;div&gt;The maximum aggregate amount of the securities to which the prospectus relates is 74,020,695 shares of Common Stock. The prospectus is a final prospectus for the related offering.&lt;/div&gt;</ffd:NrrtvDsclsr>
    <ffd:NrrtvMaxAggtAmt
      contextRef="c0"
      decimals="INF"
      id="ixv-305"
      unitRef="shares">74020695</ffd:NrrtvMaxAggtAmt>
    <ffd:FnlPrspctsFlg contextRef="c0" id="ixv-306">true</ffd:FnlPrspctsFlg>
    <ffd:SubmissnTp contextRef="c0" id="hidden-fact-0">424B2</ffd:SubmissnTp>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-310">0000797468</dei:EntityCentralIndexKey>
    <ffd:FeeExhibitTp contextRef="c0" id="ixv-311">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:FormTp contextRef="c0" id="ixv-312">S-3</ffd:FormTp>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
